Data / Research funding / California / Scripps Research Institute, the
Scripps Research Institute, the: 401 NIH awards ($1B) and 10 NSF awards ($13.2M), fiscal years 2021 to 2026
Scripps Research Institute, the in La Jolla, CA is funded under 401 NIH awards ($1B) and 10 NSF awards ($13.2M) in the NIH and NSF award files, read 2026-11-03. NIH fiscal years 2021 to 2025; NSF fiscal years 2022 to 2026.
SpecStream is the live web data engine for teams and agents. It reads the NIH and NSF award files each time the agencies update them, and this page is that reading, joined to the open federal funding opportunities on Grants.gov. Ask for the awards you track by topic, organization or state and new awards arrive in your sheet, CRM, Slack or agent as the agencies publish them.
- UEI
- PHZJFZ32NKH4
- State
- California
Awards
411 awards in the window.
| Award | Agency | Institute or division | Fiscal year | Amount in window | Start | End | Principal investigator | Source |
|---|---|---|---|---|---|---|---|---|
| Consortium for HIV/AIDS Vaccine Development | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $145,502,241 | July 1, 2019 | June 30, 2026 | BURTON, DENNIS R. | reporter.nih.gov |
| Technology to Empower Changes in Health (TECH) Network Participant Technologies Center | NIH | Office of the Director, National Institutes of Health | 2021 to 2022 | $71,400,578 | July 6, 2016 | June 30, 2023 | TOPOL, ERIC JEFFREY | reporter.nih.gov |
| Center for Antiviral Medicines & Pandemic Preparedness (CAMPP) | NIH | National Institute of Allergy and Infectious Diseases | 2022 | $67,624,156 | May 16, 2022 | April 30, 2025 | CHANDA, SUMIT K | reporter.nih.gov |
| The Participant Center: Empowering All of Us Research Program participation across the United States | NIH | Office of the Director, National Institutes of Health | 2023 to 2024 | $64,505,370 | July 1, 2024 | June 30, 2026 | TOPOL, ERIC JEFFREY | reporter.nih.gov |
| Reversing Immune Dysfunction for HIV-1 Eradication | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $20,001,273 | August 16, 2021 | October 31, 2026 | CHANDA, SUMIT K | reporter.nih.gov |
| Scripps Clinical and Translational Science Hub | NIH | National Center for Advancing Translational Sciences | 2023 to 2025 | $18,113,488 | May 1, 2023 | April 30, 2030 | TOPOL, ERIC JEFFREY | reporter.nih.gov |
| Eliciting neutralizing antibodies and B cell responses using novel HIV Env immunogens in non-human primates | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $17,277,936 | February 4, 2021 | January 31, 2027 | WYATT, RICHARD THOMAS | reporter.nih.gov |
| Center for Viral Systems Biology (CViSB) | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $16,438,330 | February 1, 2018 | January 31, 2028 | ANDERSEN, KRISTIAN GRAUGAARD | reporter.nih.gov |
| Neutrophil lineage in inflammation | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $12,398,549 | August 16, 2021 | May 31, 2027 | CATZ, SERGIO DANIEL | reporter.nih.gov |
| Scripps Translational Science Institute | NIH | National Center for Advancing Translational Sciences | 2021 to 2022 | $11,650,904 | May 1, 2018 | June 30, 2023 | TOPOL, ERIC JEFFREY | reporter.nih.gov |
| West African Emerging Infectious Disease Research Center (WA-EIDRC) | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $11,322,650 | May 21, 2020 | June 5, 2025 | ANDERSEN, KRISTIAN GRAUGAARD | reporter.nih.gov |
| CNS Effects of Alcohol: Cellular Neurobiology | NIH | National Institute on Alcohol Abuse and Alcoholism | 2021 to 2025 | $9,489,642 | December 1, 1983 | December 31, 2027 | ROBERTO, MARISA | reporter.nih.gov |
| Broadly Effective HCV Vaccine | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $8,381,005 | February 1, 2022 | January 31, 2027 | LAW, MANSUN | reporter.nih.gov |
| Cell Specific Perturbations of the Proteome in Alzheimer's Disease | NIH | National Institute on Aging | 2021 to 2025 | $6,610,744 | September 30, 2021 | July 31, 2027 | YATES III, JOHN R | reporter.nih.gov |
| Design and testing of immunogens to elicit 10E8-like broadly neutralizing antibodies against HIV | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $6,090,710 | July 8, 2019 | August 31, 2029 | SCHIFFNER, TORBEN | reporter.nih.gov |
| Multidimensional development of high-affinity anti-glycan antibodies to fight deadly bacterial infections | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $5,930,384 | May 9, 2023 | April 30, 2028 | TEYTON, LUC | reporter.nih.gov |
| Scalable Synthesis and New Bond Disconnections | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $5,750,475 | April 1, 2016 | November 30, 2026 | BARAN, PHIL S | reporter.nih.gov |
| Chemical Proteomic Platforms for Radically Expanding Cancer Druggability | NIH | National Cancer Institute | 2021 to 2025 | $5,455,828 | September 1, 2018 | August 31, 2032 | CRAVATT, BENJAMIN F | reporter.nih.gov |
| Leadership in AD/ADRD Drug Discovery | NIH | National Institute on Aging | 2021 to 2025 | $5,389,748 | September 1, 2021 | August 31, 2027 | LIPTON, STUART A | reporter.nih.gov |
| The Multi-omics Vaccine Evaluation (MOVE) Consortium | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $5,373,447 | June 1, 2023 | March 31, 2028 | BRINEY, BRYAN | reporter.nih.gov |
| Modeling drugs of abuse-HIV interactions using iPSC-derived human cerebral organoids | NIH | National Institute on Drug Abuse | 2021 to 2025 | $4,890,555 | September 30, 2021 | July 31, 2026 | SANNA, PIETRO P | reporter.nih.gov |
| NSF PCL-Test Bed: Towards a General Platform for AI-Driven High-Throughput Reaction Discovery and Automation | NSF | Emerging Technologies Section | 2026 | $4,873,120 | August 1, 2026 | July 31, 2030 | Brandon J Orzolek | nsf.gov |
| Systems Approach to Immunity and Inflammation | NIH | National Institute of Allergy and Infectious Diseases | 2021 | $4,863,630 | September 1, 2012 | August 31, 2023 | ULEVITCH, RICHARD J | reporter.nih.gov |
| Automated, optimized, intelligent data collection for cryo-EM | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $4,662,806 | September 22, 2021 | August 31, 2029 | LANDER, GABRIEL C | reporter.nih.gov |
| Single nucleus gene expression in moderate and compulsive drug self-administration in a rodent model of HIV | NIH | National Institute on Drug Abuse | 2022 to 2025 | $4,653,858 | March 15, 2022 | November 30, 2026 | SANNA, PIETRO P | reporter.nih.gov |
| Resource for Structure-based Computational Drug Discovery and Design (RSD3) | NIH | National Institute of General Medical Sciences | 2022 to 2025 | $4,636,640 | September 21, 2022 | August 31, 2027 | FORLI, STEFANO | reporter.nih.gov |
| Elicitation of HIV Broadly Neutralizing Antibodies from Engineered B cells | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $4,634,490 | July 1, 2021 | December 31, 2026 | VOSS, JAMES EVEN | reporter.nih.gov |
| Regulation of Protein C Pathways | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $4,441,427 | June 1, 2018 | March 31, 2026 | MOSNIER, LAURENT OLIVIER | reporter.nih.gov |
| Dissecting Polyclonal Sera to Reveal Correlates of Productive Immune Responses to HIV | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $4,391,888 | March 16, 2018 | February 29, 2028 | WARD, ANDREW BARRETT | reporter.nih.gov |
| Combining germline-targeting, B cell immunofocusing and Env-Ab co-evolution strategies to induce HIV Envelope V2-apex broadly neutralizing antibodies | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2023 | $4,257,922 | April 1, 2021 | June 30, 2023 | ANDRABI, RAIEES AHMAD | reporter.nih.gov |
| Graduate Research Fellowship Program (GRFP) | NSF | Scholarships, Fellowships, and Traineeships Section | 2022 | $4,072,972 | August 15, 2022 | July 31, 2027 | Keary M Engle | nsf.gov |
| BioThings Explorer: A platform for distributed knowledge integration across biomedical APIs | NIH | National Center for Advancing Translational Sciences | 2021 to 2024 | $4,068,843 | January 24, 2020 | November 30, 2024 | SU, ANDREW I | reporter.nih.gov |
| Exploring Siglec-glycan ligand interactions using chemoenzymatic approaches | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $4,052,733 | June 4, 2021 | May 31, 2026 | WU, PENG | reporter.nih.gov |
| Single nucleus gene expression in moderate and compulsive opioid self-administration in a rodent model of HIV | NIH | National Institute on Drug Abuse | 2023 to 2025 | $4,045,522 | September 1, 2023 | June 30, 2028 | SANNA, PIETRO P | reporter.nih.gov |
| Mechanisms of force sensing in the nervous system | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $4,041,195 | December 15, 2017 | November 30, 2025 | PATAPOUTIAN, ARDEM | reporter.nih.gov |
| Chemoenzymatic glycan editing for deciphering biological functions of glycans | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $4,015,088 | February 1, 2021 | January 31, 2026 | WU, PENG | reporter.nih.gov |
| Rational Systemic Characterization and Selection of Adjuvants for HIV Vaccine Candidates (R-CASA) | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $3,983,710 | August 1, 2025 | July 31, 2026 | CHATTERJEE, ARNAB KUMAR | reporter.nih.gov |
| Lowering Mitochondrial ATP Synthase Activity Slows Aging and Alzheimer's Disease | NIH | National Institute on Aging | 2021 to 2024 | $3,954,772 | May 1, 2020 | April 30, 2025 | PETRASCHECK, MICHAEL | reporter.nih.gov |
| Molecular and Cellular Mechanisms of the Lysosomal Storage Disease Cystinosis | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $3,910,982 | August 9, 2017 | May 30, 2027 | CATZ, SERGIO DANIEL | reporter.nih.gov |
| Improving The Scripps Research Institute BSL3 Capabilities to Combat Viruses of Pandemic Concern | NIH | National Institute of Allergy and Infectious Diseases | 2022 | $3,869,562 | September 16, 2022 | February 28, 2025 | DE LA TORRE, JUAN C. | reporter.nih.gov |
| Role of NLRP3 signals in ischemia/reperfusion-induced organ injury | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $3,795,629 | September 24, 2021 | June 30, 2026 | MCKAY, DIANNE B | reporter.nih.gov |
| Managing Atherosclerosis by Modulating HDL Function | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $3,778,414 | June 1, 2013 | March 31, 2026 | GHADIRI, M. REZA | reporter.nih.gov |
| Dynamics of the Bacterial Ribosome and Proteome | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $3,744,498 | April 1, 2020 | March 31, 2030 | WILLIAMSON, JAMES R | reporter.nih.gov |
| Unusual Pharmacophores and New Tools for Cross-Coupling | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $3,734,184 | April 1, 2017 | March 31, 2027 | SHENVI, RYAN ASHOK | reporter.nih.gov |
| Experience-dependent Cellular Plasticity Mechanisms | NIH | National Eye Institute | 2021 to 2025 | $3,578,100 | January 1, 2021 | December 31, 2025 | CLINE, HOLLIS T. | reporter.nih.gov |
| The generation and protective function of lung tissue resident memory T cells following SARS-CoV-2 infection or vaccination | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $3,543,436 | March 1, 2022 | February 28, 2027 | TEIJARO, JOHN ROSS | reporter.nih.gov |
| Compound repositioning for Alzheimer's Disease using knowledge graphs, insurance claims data, and gene expression complementarity | NIH | National Institute on Aging | 2021 to 2024 | $3,536,257 | April 15, 2020 | December 31, 2025 | SU, ANDREW I | reporter.nih.gov |
| Genetic, structural and functional profiling of the human antibody response to arenavirus infection | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $3,529,436 | August 22, 2022 | July 31, 2027 | BRINEY, BRYAN | reporter.nih.gov |
| PlanB2CureHIV (the 'PlanB' consortium) | NIH | National Heart, Lung, and Blood Institute | 2025 | $3,519,835 | September 5, 2025 | June 30, 2030 | VOSS, JAMES EVEN | reporter.nih.gov |
| Beyond Transcription - microRNA Regulation of Neuronal Development | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $3,516,775 | April 1, 2021 | March 31, 2026 | LIPPI, GIORDANO | reporter.nih.gov |
| Structural and Mechanistic basis for RNA Silencing | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $3,507,599 | August 1, 2018 | July 31, 2028 | MACRAE, IAN JOHN | reporter.nih.gov |
| NEUROPSYCHOPHARMACOLOGY: MULTIDISCIPLINARY TRAINING | NIH | National Institute on Alcohol Abuse and Alcoholism | 2021 to 2025 | $3,469,477 | December 1, 1983 | June 30, 2027 | ROBERTO, MARISA | reporter.nih.gov |
| Mechanistic Studies of Combination Adjuvants to Target B Cells in Vaccines | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $3,438,006 | April 23, 2021 | March 31, 2027 | TEYTON, LUC | reporter.nih.gov |
| Defining Genome Stability Mechanisms and their Regulation by SUMO and Ubiquitin | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $3,435,200 | September 1, 2020 | August 31, 2030 | BODDY, MICHAEL N | reporter.nih.gov |
| Mechanisms of Mutant Prion Protein Aggregation Within Endolysosomal Pathways | NIH | National Institute on Aging | 2022 to 2025 | $3,350,798 | May 15, 2022 | April 30, 2027 | ENCALADA, SANDRA E | reporter.nih.gov |
| 9/10 Electrophysiology of Alcohol in Extended Amygdala | NIH | National Institute on Alcohol Abuse and Alcoholism | 2021 to 2025 | $3,330,627 | September 27, 2001 | January 31, 2027 | ROBERTO, MARISA | reporter.nih.gov |
| Proteogenetics of Autism Spectrum Disorders | NIH | National Institute of Mental Health | 2021 to 2025 | $3,288,305 | August 1, 2013 | June 30, 2027 | YATES III, JOHN R | reporter.nih.gov |
| Probing the biochemical mechanism of amyloid disease | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $3,210,642 | May 1, 1993 | June 30, 2026 | KELLY, JEFFERY W | reporter.nih.gov |
| IMPACTING MITOCHONDRIAL FUNCTION THROUGH ALTERED PROTEASE ACTIVITY | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $3,195,125 | April 1, 2016 | June 30, 2026 | WISEMAN, ROCKLAND LUKE | reporter.nih.gov |
| Chemoproteomic-Enabled Strategy to Study SLC Transporter Roles in Inflammation | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $3,147,169 | July 1, 2021 | June 30, 2026 | PARKER, CHRISTOPHER G | reporter.nih.gov |
| Design of single-shot sequential immunization regimens for HIV using atomic layer deposition technology. | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $3,017,032 | August 8, 2025 | July 31, 2029 | IRVINE, DARRELL J | reporter.nih.gov |
| Brain-wide mapping of neuronal inhibition by novel inverse activity markers | NIH | National Institute of Mental Health | 2023 | $3,013,502 | May 2, 2023 | April 30, 2026 | YE, LI | reporter.nih.gov |
| Salivary gland ionocyte organization and function during homeostasis, repair, and disease | NIH | National Institute of Dental & Craniofacial Research | 2021 to 2025 | $2,994,334 | August 18, 2021 | May 31, 2027 | MAKARENKOVA, HELEN P. | reporter.nih.gov |
| The Role of Sensory Neurons Innervating Internal Organs | NIH | National Center for Complementary & Integrative Health | 2022 to 2025 | $2,947,192 | August 18, 2022 | May 31, 2027 | PATAPOUTIAN, ARDEM | reporter.nih.gov |
| CTSA K12 Program at The Scripps Research Institute | NIH | National Center for Advancing Translational Sciences | 2023 to 2025 | $2,917,786 | July 1, 2023 | June 30, 2028 | NICHOLSON, LAURA | reporter.nih.gov |
| Uncleaved prefusion-optimized trimers on nanoparticles as HIV vaccines | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2023 | $2,907,216 | December 1, 2018 | August 31, 2024 | ZHU, JIANG | reporter.nih.gov |
| Engineer Immune Cells via Chemoenzymatic Glycan Editing | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2023 | $2,832,957 | March 1, 2019 | February 28, 2025 | WU, PENG | reporter.nih.gov |
| In vivo engineering of B cells for the secretion of HIV broadly neutralizing antibodies | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $2,818,132 | December 3, 2021 | November 30, 2026 | VOSS, JAMES EVEN | reporter.nih.gov |
| Analysis of protein interactions in neurodegenerative disease | NIH | National Institute on Aging | 2022 to 2025 | $2,811,410 | May 1, 2022 | April 30, 2027 | YATES III, JOHN R | reporter.nih.gov |
| Building a somatosensory atlas for interoception | NIH | National Center for Complementary & Integrative Health | 2025 | $2,804,900 | August 15, 2025 | May 31, 2030 | PATAPOUTIAN, ARDEM | reporter.nih.gov |
| Discovering Small Molecule Activators of Stress-Responsive Signaling | NIH | National Institute on Aging | 2023 to 2025 | $2,790,525 | April 1, 2013 | March 31, 2026 | KELLY, JEFFERY W | reporter.nih.gov |
| FoxO transcription factors in joint aging and osteoarthritis pathogenesis | NIH | National Institute on Aging | 2021 to 2025 | $2,771,759 | May 15, 2018 | May 31, 2028 | LOTZ, MARTIN K | reporter.nih.gov |
| Expediting elicitation of HIV-1 bnAbs with membrane Env vaccines | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2023 | $2,731,401 | March 9, 2020 | April 30, 2024 | ZWICK, MICHAEL B | reporter.nih.gov |
| Ligand-promoted Enantioselective C-H Activation Reactions | NIH | National Institute of General Medical Sciences | 2021 to 2024 | $2,729,902 | August 1, 2008 | June 30, 2025 | YU, JIN-QUAN | reporter.nih.gov |
| The role of IL-27 in sustaining the exhausted CD8 T cell response to persistent infection and cancer. | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $2,729,120 | July 6, 2021 | June 30, 2027 | TEIJARO, JOHN ROSS | reporter.nih.gov |
| High-throughput assays and small-molecule discovery of antiviral candidates targeting influenza hemagglutinin | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $2,727,483 | May 1, 2021 | April 30, 2026 | WILSON, IAN A | reporter.nih.gov |
| Identifying specific genetic pathway interactions for drug use and abuse through integrative omics | NIH | National Institute on Drug Abuse | 2021 to 2025 | $2,712,000 | September 1, 2021 | July 31, 2027 | PENG, QIAN | reporter.nih.gov |
| Transcriptional Control of Synaptic Plasticity by Class IIa HDACs | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2024 | $2,711,314 | April 1, 2014 | March 31, 2026 | MAXIMOV, ANTON | reporter.nih.gov |
| Synthesis at the Interface of Chemistry and Biology | NIH | National Institute of General Medical Sciences | 2022 to 2025 | $2,695,714 | April 1, 2022 | March 31, 2027 | SCHULTZ, PETER G | reporter.nih.gov |
| Using Genetic Diversity to Manage Neurological Disease | NIH | National Institute on Aging | 2021 to 2025 | $2,692,377 | January 1, 2021 | December 31, 2026 | BALCH, WILLIAM EDWARD | reporter.nih.gov |
| Fusion peptide directed immunogens that elicit neutralizing and protective antibodies in non-human primates | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $2,658,042 | March 18, 2019 | February 28, 2025 | WARD, ANDREW BARRETT | reporter.nih.gov |
| Vesicular trafficking mechanisms regulating granulocyte function | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $2,638,898 | December 3, 2008 | July 31, 2027 | CATZ, SERGIO DANIEL | reporter.nih.gov |
| Contributions of cell type and exosome signaling to prodromal synaptic and circuit changes in Alzheimer's Disease models | NIH | National Institute on Aging | 2022 | $2,618,631 | August 15, 2022 | July 31, 2025 | CLINE, HOLLIS T. | reporter.nih.gov |
| Determinants of HIV-1 innate immune sensing and its role in shaping the lymphoid environment. | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $2,608,004 | July 12, 2023 | June 30, 2027 | YOH, SUNNIE | reporter.nih.gov |
| Pharmacologic Lysosomal Flux Activators to Ameliorate Alzheimer's Disease and Related Dementias | NIH | National Institute on Aging | 2021 | $2,601,749 | September 1, 2021 | August 31, 2024 | KELLY, JEFFERY W | reporter.nih.gov |
| Probing the Proteinopathy Component of Light Chain Amyloidosis Pharmacologically | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $2,547,423 | July 1, 2021 | May 31, 2029 | KELLY, JEFFERY W | reporter.nih.gov |
| Omics Analyses of HIV and Substance Use Disorder | NIH | National Institute on Drug Abuse | 2021 to 2023 | $2,546,508 | September 30, 2019 | July 31, 2025 | REPUNTE-CANONIGO, VEZ | reporter.nih.gov |
| HIV-1 vaccine design emphasizing bnAb targets on membrane Env liposomes | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2023 | $2,533,821 | August 1, 2019 | August 31, 2025 | ZWICK, MICHAEL B | reporter.nih.gov |
| Metabolomics Technologies to Advance Biomedical Research | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $2,516,384 | March 1, 2019 | March 31, 2029 | SIUZDAK, GARY E | reporter.nih.gov |
| Mapping brain-wide opioid actions by profiling neuronal activities and in vivo cellular target engagement | NIH | National Institute on Drug Abuse | 2023 to 2025 | $2,499,976 | September 30, 2023 | June 30, 2028 | YE, LI | reporter.nih.gov |
| Investigating DNA double-strand break repair mechanisms in mammalian cells | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $2,497,619 | April 1, 2021 | January 31, 2026 | WU, XIAOHUA | reporter.nih.gov |
| Understanding human antibody responses to chronic viral hepatitis C | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $2,488,538 | January 17, 2022 | December 31, 2026 | LAW, MANSUN | reporter.nih.gov |
| Integrative Omics analysis of human cartilage in aging and osteoarthritis | NIH | National Institute on Aging | 2021 to 2024 | $2,482,844 | January 15, 2016 | May 31, 2026 | LOTZ, MARTIN K | reporter.nih.gov |
| Defining Endoplasmic Reticulum Stress-Development Mitochondria Remodeling | NIH | National Institute of Neurological Disorders and Stroke | 2022 | $2,356,233 | August 20, 2022 | June 30, 2025 | WISEMAN, ROCKLAND LUKE | reporter.nih.gov |
| AutoDock Suite: High Performance Software Environment for Drug Design | NIH | National Institute of General Medical Sciences | 2022 to 2025 | $2,349,826 | January 1, 2004 | July 31, 2026 | FORLI, STEFANO | reporter.nih.gov |
| Modulation of Lung Disease by Genetic/Epigenetic Profiling | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $2,332,500 | April 1, 2010 | May 31, 2027 | BALCH, WILLIAM EDWARD | reporter.nih.gov |
| Microbiota, Probiotic and Dietary Metabolite Control of Enteric Pathogen Virulence | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $2,318,817 | November 10, 2022 | October 31, 2027 | HANG, HOWARD C | reporter.nih.gov |
| Ribo-STAMPEDE: novel tools for molecular profiling of brain cell types | NIH | National Institute of Mental Health | 2022 | $2,308,022 | August 1, 2022 | July 31, 2025 | LIPPI, GIORDANO | reporter.nih.gov |
| Genotype First: Actionable Genetic Risk through Genotype-to-Phenotype Prediction | NIH | National Human Genome Research Institute | 2021 to 2023 | $2,287,236 | August 21, 2020 | May 31, 2024 | TORKAMANI, ALI | reporter.nih.gov |
| Exploring the Functions of tRNA Synthetases in the Nucleus and their Relationship to CMT | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2024 | $2,285,535 | April 1, 2020 | March 31, 2025 | YANG, XIANG-LEI | reporter.nih.gov |
| In vivo Perturb-map: scalable genetic screens with single-cell and spatial resolution in intact tissues | NIH | National Human Genome Research Institute | 2023 to 2025 | $2,265,169 | March 2, 2023 | December 31, 2027 | JIN, XIN | reporter.nih.gov |
| Link extracellular function of tRNA synthetase with pathological mechanism of disease | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $2,260,000 | June 1, 2021 | August 31, 2026 | YANG, XIANG-LEI | reporter.nih.gov |
| Bridging the Glycome and Proteome with Chemical Biology | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $2,248,513 | June 1, 2021 | May 31, 2026 | HUANG, MIA L | reporter.nih.gov |
| Cancer genes: translating basics to applications | NIH | National Cancer Institute | 2021 to 2022 | $2,236,257 | January 8, 2016 | April 30, 2023 | VOGT, PETER K | reporter.nih.gov |
| Toward Personalized Therapeutics: Directed Remodeling of the Gut Microbiome to Treat Atherosclerosis | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $2,216,742 | April 22, 2020 | September 30, 2024 | GHADIRI, M. REZA | reporter.nih.gov |
| Identification and Verification of S-Nitrosylated Proteins in Bodily Fluids as Biomarkers for Parkinson's Disease and Lewy Body Dementia | NIH | National Institute of Neurological Disorders and Stroke | 2021 | $2,199,931 | July 1, 2021 | June 30, 2025 | NAKAMURA, TOMOHIRO | reporter.nih.gov |
| How antigen exposure shapes the subsequent NK cell response to HIV | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2023 | $2,169,459 | March 18, 2021 | August 2, 2023 | PAUST, SILKE | reporter.nih.gov |
| Expanding the landscape of Translator Knowledge Providers using BioThings SDK and SmartAPI | NIH | National Center for Advancing Translational Sciences | 2021 to 2024 | $2,162,697 | January 24, 2020 | November 30, 2024 | WU, CHUNLEI | reporter.nih.gov |
| The CFTR Interactome | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,146,994 | August 5, 2022 | July 31, 2027 | YATES III, JOHN R | reporter.nih.gov |
| Dorsal striatal phosphodiesterase 10A and compulsive ethanol use | NIH | National Institute on Alcohol Abuse and Alcoholism | 2021 to 2025 | $2,145,748 | January 15, 2021 | August 31, 2026 | ZORRILLA, ERIC P | reporter.nih.gov |
| Early Pathogenic Steps in Xenobiotic-Induced Autoimmunity | NIH | National Institute of Environmental Health Sciences | 2022 to 2025 | $2,123,849 | February 24, 2022 | November 30, 2026 | POLLARD, KENNETH MICHAEL | reporter.nih.gov |
| Neural Mechanisms of Energy Expenditure-Induced Compensatory Food Intake | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2023 to 2025 | $2,103,793 | July 20, 2023 | April 30, 2027 | YE, LI | reporter.nih.gov |
| Haplotype-aware models of gene and isoform expression with application to genetic studies of disease in diverse populations | NIH | National Institute of General Medical Sciences | 2021 to 2023 | $2,088,781 | March 1, 2021 | April 30, 2023 | MOHAMMADI, PEJMAN | reporter.nih.gov |
| S-Nitrosylation-Dependent Pathological Spread of Abnormal Proteins in Frontotemporal Dementia and Lewy Body Dementia | NIH | National Institute of Neurological Disorders and Stroke | 2021 | $2,081,944 | August 1, 2021 | July 31, 2024 | NAKAMURA, TOMOHIRO | reporter.nih.gov |
| Institutional Career Development Core | NIH | National Center for Advancing Translational Sciences | 2021 to 2022 | $2,080,132 | May 1, 2018 | June 30, 2023 | NICHOLSON, LAURA | reporter.nih.gov |
| Lacrimal Gland Repair Using Progenitor Cells | NIH | National Eye Institute | 2021 to 2025 | $2,077,504 | January 1, 2016 | June 30, 2027 | MAKARENKOVA, HELEN P. | reporter.nih.gov |
| Modulating Signaling Endocannabinoids and Fatty Acid Amides | NIH | National Institute on Drug Abuse | 2021 to 2025 | $2,053,125 | December 1, 2021 | November 30, 2026 | BOGER, DALE L | reporter.nih.gov |
| Establishing Strategies to Ameliorate Amyloid Pathology in Light Chain Amyloidosis | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $2,046,018 | May 5, 2016 | June 30, 2025 | WISEMAN, ROCKLAND LUKE | reporter.nih.gov |
| Studying the mechanisms underlying the protection of common fragile sites and structure-prone DNA sequences | NIH | National Cancer Institute | 2021 to 2025 | $2,003,692 | August 1, 2015 | May 31, 2026 | WU, XIAOHUA | reporter.nih.gov |
| Knock-in mice expressing germline-reverted broadly neutralizing HIV antibodies | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2023 | $1,993,554 | July 5, 2019 | June 30, 2024 | NEMAZEE, DAVID | reporter.nih.gov |
| Identification of small molecules for neurological complications of HIV and substance abuse comorbidity | NIH | National Institute on Drug Abuse | 2021 to 2022 | $1,974,420 | April 1, 2018 | January 31, 2024 | SANNA, PIETRO P | reporter.nih.gov |
| Study of Break-induced Replication in Mammalian Cells | NIH | National Cancer Institute | 2021 to 2024 | $1,970,649 | December 10, 2019 | November 30, 2025 | WU, XIAOHUA | reporter.nih.gov |
| Novel functions of Thrombin Activatable Fibrinolysis Inhibitor (TAFI) | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $1,967,120 | April 1, 2020 | July 31, 2024 | MOSNIER, LAURENT OLIVIER | reporter.nih.gov |
| Translation of commensal bacteria mechanism for immunotherapy | NIH | National Cancer Institute | 2021 to 2024 | $1,965,036 | December 2, 2019 | November 30, 2024 | HANG, HOWARD C | reporter.nih.gov |
| Molecular mechanisms of structural plasticity of inhibitory GABAergic interneurons | NIH | National Institute of Mental Health | 2021 to 2023 | $1,959,206 | June 13, 2019 | April 30, 2025 | MAXIMOV, ANTON | reporter.nih.gov |
| Functional Analysis of MicroRNAs and Target Genes in Immune Tolerance | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $1,948,146 | June 5, 2019 | May 31, 2025 | NEMAZEE, DAVID | reporter.nih.gov |
| Molecular mechanisms of transthyretin amyloidosis | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $1,944,980 | April 1, 2020 | December 31, 2028 | WRIGHT, PETER EDWIN | reporter.nih.gov |
| N-glycan baiting to target the highly effective HIV Env shield | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2023 | $1,923,596 | April 19, 2019 | March 31, 2024 | WYATT, RICHARD THOMAS | reporter.nih.gov |
| Covalent Inhibition as a Method to Counteract Botulinum Intoxication | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2023 | $1,905,848 | June 2, 2020 | November 30, 2024 | JANDA, KIM | reporter.nih.gov |
| Gene Network Perturbations in Alcohol Dependence - A Systems BiologyApproach | NIH | National Institute on Alcohol Abuse and Alcoholism | 2021 to 2023 | $1,904,560 | September 5, 2013 | August 31, 2024 | SANNA, PIETRO P | reporter.nih.gov |
| UNDERSTANDING HEPATIC PROTEOSTASIS IN SYSTEMIC AMYLOID DISEASES | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2023 | $1,891,335 | July 14, 2020 | March 31, 2024 | WISEMAN, ROCKLAND LUKE | reporter.nih.gov |
| Targeting Influenza A Virus by a Carbohydrate-inspired Strategy | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $1,866,200 | September 18, 2019 | December 31, 2027 | WONG, CHI-HUEY | reporter.nih.gov |
| Combining membrane Env vaccine regimens to elicit multiple bnAb lineages and consistent cross-neutralization of HIV | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $1,866,100 | December 1, 2023 | October 31, 2028 | ZWICK, MICHAEL B | reporter.nih.gov |
| An Innovative Approach to Identify Correctors of Metabolic Complications in HIV | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2024 to 2025 | $1,860,972 | January 15, 2024 | November 30, 2028 | SANNA, PIETRO P | reporter.nih.gov |
| Modeling and Interacting with the Visible Molecular Cell | NIH | National Institute of General Medical Sciences | 2022 to 2025 | $1,831,074 | September 15, 2016 | July 31, 2027 | AUTIN, LUDOVIC | reporter.nih.gov |
| Influenza virus receptors on human airway epithelial cells | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2023 | $1,818,983 | September 3, 2015 | July 31, 2025 | PAULSON, JAMES C | reporter.nih.gov |
| Methods and approaches to expand the pharmacological toolset | NIH | National Institute of General Medical Sciences | 2022 to 2025 | $1,816,250 | August 15, 2022 | June 30, 2027 | BOLLONG, MICHAEL J | reporter.nih.gov |
| Aberrant protein S-nitrosylation mediates Gene-Environment Interactions in AD/ADRD | NIH | National Institute on Aging | 2024 to 2025 | $1,809,238 | September 15, 2024 | June 30, 2029 | LIPTON, STUART A | reporter.nih.gov |
| Crosstalk between innate-immunity human microglia and adaptive-immunity Tregs in Alzheimer's disease | NIH | National Institute on Aging | 2022 to 2025 | $1,807,050 | September 1, 2022 | May 31, 2027 | LIPTON, STUART A | reporter.nih.gov |
| Biologically Active Cyclic Peptides | NIH | National Cancer Institute | 2021 to 2024 | $1,806,081 | July 1, 1985 | November 30, 2025 | BOGER, DALE L | reporter.nih.gov |
| Neural Basis of alcohol/substance use disorders and suicide in American Indians | NIH | National Institute on Alcohol Abuse and Alcoholism | 2021 to 2023 | $1,804,628 | February 5, 2019 | September 30, 2025 | EHLERS, CINDY L | reporter.nih.gov |
| Scalable functional analysis of neuropsychiatric risk genes with spatially integrated in vivo Perturb-seq | NIH | National Institute of Mental Health | 2024 to 2025 | $1,802,858 | September 5, 2024 | May 31, 2029 | JIN, XIN | reporter.nih.gov |
| Establishing a mechanistic basis for enhanced tumorigenesis under chronic circadian disruption | NIH | National Cancer Institute | 2023 to 2025 | $1,802,817 | December 15, 2022 | November 30, 2027 | LAMIA, KATJA A | reporter.nih.gov |
| Regulation of cellular functions by the plasminogen receptor, Plg-RKT | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $1,800,000 | April 6, 2007 | March 31, 2025 | MILES, LINDSEY A | reporter.nih.gov |
| Structure-function of cytoprotective coagulation proteases and their receptors | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $1,792,500 | December 1, 2010 | March 31, 2025 | MOSNIER, LAURENT OLIVIER | reporter.nih.gov |
| Effects of alcohol on sleep/activity rhythms: Focus on Hypocretin/Orexin | NIH | National Institute on Alcohol Abuse and Alcoholism | 2022 to 2025 | $1,791,352 | September 1, 1992 | June 30, 2027 | EHLERS, CINDY L | reporter.nih.gov |
| Non-immunosuppressive Sanglifehrin Analogs as Therapeutic Agents for Viral Hepatitis-induced Liver Damage Development | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $1,783,750 | April 1, 2020 | March 31, 2026 | GALLAY, PHILIPPE ANDRE | reporter.nih.gov |
| Pharmacologic Lysosomal Flux Activators to Ameliorate Alzheimer's Disease and Related Dementias | NIH | National Institute on Aging | 2024 to 2025 | $1,778,822 | September 1, 2021 | August 31, 2026 | KELLY, JEFFERY W | reporter.nih.gov |
| Gene-environment interaction: the brain CRF system in alcohol preferring msP rats | NIH | National Institute on Alcohol Abuse and Alcoholism | 2021 to 2025 | $1,774,951 | July 1, 2021 | June 30, 2027 | ROBERTO, MARISA | reporter.nih.gov |
| Systems biology of RNA Modifications in HIV/AIDS and Substance Use Disorders | NIH | National Institute on Drug Abuse | 2021 to 2022 | $1,760,840 | March 15, 2018 | December 31, 2023 | SANNA, PIETRO P | reporter.nih.gov |
| Managing Alpha-1-Antitrypsin Deficiency (AATD) through Proteostasis Signaling Pathways | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $1,759,301 | March 15, 2024 | February 29, 2028 | BALCH, WILLIAM EDWARD | reporter.nih.gov |
| DOGSURF: Database Optimized for Graph Search Using Robust Federation | NIH | National Center for Advancing Translational Sciences | 2025 | $1,746,403 | December 24, 2024 | November 30, 2026 | SU, ANDREW I | reporter.nih.gov |
| Antitumor Antibiotics | NIH | National Cancer Institute | 2021 to 2024 | $1,702,340 | February 1, 1986 | March 31, 2026 | BOGER, DALE L | reporter.nih.gov |
| Immune engineering of optimized sequential immunization strategies for HIV vaccines | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $1,687,928 | April 1, 2021 | June 30, 2026 | IRVINE, DARRELL J | reporter.nih.gov |
| Deconvolution of Galbulimima bark pharmacology through chemical synthesis and target assignment | NIH | National Center for Complementary & Integrative Health | 2023 to 2025 | $1,661,440 | June 8, 2023 | February 28, 2027 | SHENVI, RYAN ASHOK | reporter.nih.gov |
| Regulation of inflammation by nociception | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2024 | $1,656,000 | September 4, 2024 | August 31, 2027 | MENDOZA, ALEJANDRA | reporter.nih.gov |
| Leveraging membrane Env liposome vaccine design to elicit multi-target cross-neutralization of HIV | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $1,655,736 | March 18, 2024 | February 29, 2028 | ZWICK, MICHAEL B | reporter.nih.gov |
| Chemoproteomic Identification and Therapeutic Validation of Proteins of Metabolic Significance | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 | $1,640,587 | August 1, 2017 | July 31, 2023 | SAEZ, ENRIQUE | reporter.nih.gov |
| High-Throughput Screen for the Oncoprotein MYC | NIH | National Cancer Institute | 2021 to 2024 | $1,638,999 | July 1, 2021 | June 30, 2025 | JANDA, KIM | reporter.nih.gov |
| Adaptations to chronic activation of BK channels by ethanol: Contribution to dependence and tolerance | NIH | National Institute on Alcohol Abuse and Alcoholism | 2022 to 2024 | $1,638,369 | January 15, 2020 | August 31, 2025 | CONTET, CANDICE | reporter.nih.gov |
| Developing a CRISPR-free mammalian recombineering system | NIH | National Institute of General Medical Sciences | 2024 | $1,638,033 | September 1, 2024 | August 31, 2027 | MILLER, SHANNON MARIE | reporter.nih.gov |
| Alcohol-Induced Neuroinflammation and AUD Therapeutic Mechanisms | NIH | National Institute on Alcohol Abuse and Alcoholism | 2022 to 2025 | $1,627,875 | March 1, 2022 | February 28, 2027 | SANNA, PIETRO P | reporter.nih.gov |
| Synaptic Mechanisms underlying sex-differences in alcohol use disorder | NIH | National Institute on Alcohol Abuse and Alcoholism | 2022 to 2025 | $1,627,875 | April 10, 2022 | March 31, 2027 | ROBERTO, MARISA | reporter.nih.gov |
| Neuroplasticity of the Extended Amygdala CRF circuitry in alcohol dependence | NIH | National Institute on Alcohol Abuse and Alcoholism | 2021 to 2024 | $1,605,375 | July 1, 2013 | December 31, 2025 | ROBERTO, MARISA | reporter.nih.gov |
| Cytochrome P-450 Polymorphism | NIH | National Institute of General Medical Sciences | 2021 to 2022 | $1,599,390 | August 1, 1982 | July 31, 2023 | JOHNSON, ERIC F | reporter.nih.gov |
| The dark side of addiction: Significance of environmental conditioning to negative reinforcement by EtOH in subjects with a dependence history | NIH | National Institute on Alcohol Abuse and Alcoholism | 2021 to 2024 | $1,598,096 | January 1, 2020 | December 31, 2025 | WEISS, FRIEDBERT | reporter.nih.gov |
| Molecular understanding of membrane sensors | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $1,582,015 | April 1, 2019 | September 30, 2023 | WARD, ANDREW BARRETT | reporter.nih.gov |
| Early diagnosis and mechanistic studies of type 1 diabetes using single cell analysis | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2022 | $1,577,236 | March 15, 2019 | December 31, 2023 | TEYTON, LUC | reporter.nih.gov |
| Structural Studies of Large Dynamic Complexes | NIH | National Institute of General Medical Sciences | 2021 to 2023 | $1,544,130 | June 1, 2019 | May 31, 2024 | DYSON, HELEN JANE | reporter.nih.gov |
| Mechano signals regulating tendon and ligament homeostasis | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2022 to 2025 | $1,537,976 | September 20, 2022 | July 31, 2027 | ASAHARA, HIROSHI | reporter.nih.gov |
| Intracellular trafficking of the essential signaling metabolite heme in myeloid cells: impact on physiology and disease | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2024 to 2025 | $1,534,767 | August 13, 2024 | July 31, 2028 | SAEZ, ENRIQUE | reporter.nih.gov |
| Internal State Sensing Via The Gut-Brain Axis | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2023 | $1,528,809 | September 24, 2020 | August 31, 2025 | SRINIVASAN, SUPRIYA | reporter.nih.gov |
| A NOVEL STRATEGY TO INHIBIT SARS-COV-2 INFECTION AND COVID-19 | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $1,525,325 | June 13, 2024 | April 30, 2029 | GALLAY, PHILIPPE ANDRE | reporter.nih.gov |
| Inhibition or evasion of P-glycoprotein-mediated drug transport | NIH | National Institute of General Medical Sciences | 2023 to 2025 | $1,505,241 | August 10, 2023 | May 31, 2027 | ZHANG, QINGHAI | reporter.nih.gov |
| Leveraging Human iPSC-derived beta-cells to Probe Antigen Specificity of Anti-islet Memory T Cells in T1D | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2023 to 2024 | $1,503,173 | February 1, 2023 | July 31, 2025 | TEYTON, LUC | reporter.nih.gov |
| Circadian regulation of HIF2alpha in ccRCC | NIH | National Cancer Institute | 2021 to 2025 | $1,500,719 | August 1, 2017 | May 31, 2029 | LAMIA, KATJA A | reporter.nih.gov |
| A RIPK2-Targeting Apoptosis-Inducing Small Molecule for the Treatment of Glioblastoma | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2023 | $1,492,646 | June 1, 2019 | March 31, 2024 | LAIRSON, LUKE LEE | reporter.nih.gov |
| A Novel Plasminogen Receptor Promotes Adipose Function and Metabolic Homeostasis | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $1,464,514 | May 1, 2019 | April 30, 2024 | MILES, LINDSEY A | reporter.nih.gov |
| Decoding vomeronasal activity through awake, behaving AOB imaging. | NIH | National Institute on Deafness and Other Communication Disorders | 2024 to 2025 | $1,454,597 | March 1, 2024 | February 28, 2029 | STOWERS, LISA | reporter.nih.gov |
| Biophysics of Protein Disorder and Complexity, Single Molecules to Mesoscales | NIH | National Institute of General Medical Sciences | 2021 to 2023 | $1,451,250 | January 1, 2019 | December 31, 2023 | DENIZ, ASHOK A | reporter.nih.gov |
| Functions of novel phospholipase D proteins in nucleic acid sensing | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2023 | $1,451,250 | June 14, 2019 | February 28, 2025 | NEMAZEE, DAVID | reporter.nih.gov |
| High-resolution deconvolution of selection effects on the composition of the B cell repertoire | NIH | National Institute of General Medical Sciences | 2021 to 2023 | $1,451,250 | August 1, 2019 | July 31, 2024 | BRINEY, BRYAN | reporter.nih.gov |
| Pharmacologic targeting of the UPR in obesity-linked liver dysfunction | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2024 to 2025 | $1,443,302 | January 15, 2024 | November 30, 2027 | SAEZ, ENRIQUE | reporter.nih.gov |
| Identifying, manipulating, and studying a complete sensory-to-motor model behavior circuit | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2022 | $1,431,218 | September 30, 2018 | July 31, 2023 | STOWERS, LISA | reporter.nih.gov |
| S-Nitrosylation-Dependent Pathological Spread of Abnormal Proteins in Frontotemporal Dementia and Lewy Body Dementia | NIH | National Institute of Neurological Disorders and Stroke | 2024 to 2025 | $1,431,052 | August 1, 2021 | July 31, 2027 | NAKAMURA, TOMOHIRO | reporter.nih.gov |
| Investigating the anti-inflammatory mechanisms of calorie restriction in the aged lacrimal gland | NIH | National Eye Institute | 2024 to 2025 | $1,430,827 | June 1, 2024 | February 28, 2029 | MAKARENKOVA, HELEN P. | reporter.nih.gov |
| Neuroimmune mechanisms in stress and alcohol comorbidity | NIH | National Institute on Alcohol Abuse and Alcoholism | 2021 to 2023 | $1,426,899 | September 1, 2019 | June 30, 2025 | ROBERTO, MARISA | reporter.nih.gov |
| eDyNAmiC - SCRIPPS | NIH | National Cancer Institute | 2022 to 2025 | $1,424,509 | June 1, 2025 | May 31, 2026 | CRAVATT, BENJAMIN F | reporter.nih.gov |
| RNA Recombination in Coronaviruses | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $1,411,961 | April 1, 2023 | March 31, 2028 | ROUTH, ANDREW LAURENCE | reporter.nih.gov |
| Germline targeting influenza immunogens | NIH | National Institute of Allergy and Infectious Diseases | 2021 | $1,394,075 | August 10, 2017 | July 31, 2024 | NEMAZEE, DAVID | reporter.nih.gov |
| The Nociceptin ORL1 System: Treatment Target for Relapse | NIH | National Institute on Alcohol Abuse and Alcoholism | 2022 to 2025 | $1,392,314 | September 1, 2004 | May 31, 2027 | WEISS, FRIEDBERT | reporter.nih.gov |
| Engineering durable immunity by optimizing HIV vaccine parameters to drive long-lived plasma cell development | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $1,379,954 | August 21, 2025 | July 31, 2030 | BRINEY, BRYAN | reporter.nih.gov |
| Structural characterization of large eukaryotic proteins containing both folded and disordered domains | NIH | National Institute of General Medical Sciences | 2023 to 2025 | $1,372,500 | September 21, 2023 | July 31, 2028 | WRIGHT, PETER EDWIN | reporter.nih.gov |
| Innate lymphocyte responses to early-life infections | NIH | National Institute of General Medical Sciences | 2023 to 2025 | $1,372,500 | August 1, 2023 | May 31, 2028 | CONSTANTINIDES, MICHAEL GEORGE | reporter.nih.gov |
| Applying Spatial Covariance to Understand Human Variation in Genetic Disease | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $1,372,500 | August 1, 2023 | April 30, 2027 | BALCH, WILLIAM EDWARD | reporter.nih.gov |
| Molecular pathogenesis of COVID-19-associated coagulopathy and new therapeutic approaches | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $1,359,177 | January 1, 2024 | December 31, 2028 | AIOLFI, ROBERTO | reporter.nih.gov |
| A platform to identify in vivo targets of covalent cancer drugs in 3D tissues | NIH | National Cancer Institute | 2023 to 2025 | $1,344,104 | September 19, 2023 | August 31, 2026 | YE, LI | reporter.nih.gov |
| Sulfur(VI) Fluoride Exchange (SuFEx): new developments and biological applications | NIH | National Institute of General Medical Sciences | 2021 to 2023 | $1,331,250 | January 1, 2016 | January 31, 2024 | SHARPLESS, KARL BARRY | reporter.nih.gov |
| Role of PLD3 in nucleic acid recognition and brain function | NIH | National Institute on Aging | 2022 | $1,331,250 | August 15, 2022 | July 31, 2025 | NEMAZEE, DAVID | reporter.nih.gov |
| Individual and community influences on alcohol use disorders and other mental health behaviors in Mexican Americans | NIH | National Institute on Alcohol Abuse and Alcoholism | 2021 to 2022 | $1,322,948 | June 1, 2018 | April 30, 2025 | EHLERS, CINDY L | reporter.nih.gov |
| Enhancing durability of V3 glycan vaccine responses in rhesus macaques | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $1,285,304 | August 1, 2025 | July 31, 2030 | STEICHEN, JON | reporter.nih.gov |
| Intestine to adipose tissue interorgan communication in homeostasis and obesity | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2024 to 2025 | $1,281,524 | September 15, 2024 | June 30, 2029 | DROUJININE, ILIA | reporter.nih.gov |
| Structure-function studies of DELE1-mediated activation of the integrated stress response | NIH | National Institute on Aging | 2024 to 2025 | $1,252,681 | August 15, 2024 | April 30, 2029 | WISEMAN, ROCKLAND LUKE | reporter.nih.gov |
| Studying the mechanisms of initiation and progression of Beta cell death in T1D | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2025 | $1,232,846 | January 1, 2025 | December 31, 2026 | TEYTON, LUC | reporter.nih.gov |
| Exploiting inhibitory Siglecs for desensitizing mast cells | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $1,225,338 | September 24, 2018 | August 31, 2023 | PAULSON, JAMES C | reporter.nih.gov |
| Investigating DNA polymerase O in replication stress and cancer therapy | NIH | National Cancer Institute | 2024 to 2025 | $1,217,313 | September 1, 2024 | August 31, 2029 | WU, XIAOHUA | reporter.nih.gov |
| In-silico prediction of protein-peptide interactions. | NIH | National Institute of General Medical Sciences | 2021 to 2023 | $1,206,000 | April 15, 2011 | June 30, 2025 | SANNER, MICHEL F. | reporter.nih.gov |
| Discovering Small Molecule Activators of Stress-responsive Signaling | NIH | National Institute on Aging | 2021 to 2022 | $1,203,446 | April 1, 2013 | March 31, 2023 | KELLY, JEFFERY W | reporter.nih.gov |
| FOXO transcription factors as critical regulators of intervertebral disc aging | NIH | National Institute on Aging | 2021 to 2023 | $1,190,025 | August 1, 2019 | April 30, 2026 | LOTZ, MARTIN K | reporter.nih.gov |
| Cancer-specific dependencies within the NuRD chromatin remodeler complex: new targets and chemical tools | NIH | National Cancer Institute | 2024 to 2025 | $1,151,174 | January 1, 2024 | December 31, 2028 | ERB, MICHAEL A | reporter.nih.gov |
| Catalyst-Controlled Site-Selective C-H Functionalizations of Arenes and Heteroarenes | NIH | National Institute of General Medical Sciences | 2021 to 2023 | $1,148,079 | September 5, 2012 | July 31, 2024 | YU, JIN-QUAN | reporter.nih.gov |
| Neuronal Orchestration of Metabolic State and Longevity | NIH | National Institute on Aging | 2021 to 2022 | $1,123,848 | March 15, 2018 | February 29, 2024 | SRINIVASAN, SUPRIYA | reporter.nih.gov |
| An in vivo screening system for chemical modulators of eating behavior | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2022 | $1,081,115 | August 1, 2018 | April 30, 2023 | PETRASCHECK, MICHAEL | reporter.nih.gov |
| Extensive drug histories result in compulsive appetite: functional identification of punishment-reactive neural network re-organization in the rostromedial tegmental nucleus | NIH | National Institute on Drug Abuse | 2022 to 2023 | $1,042,506 | September 1, 2022 | April 26, 2024 | SUTO, NOBUYOSHI | reporter.nih.gov |
| Impact of Heme Homeostasis on Adipocyte Function | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2022 | $1,033,954 | July 9, 2019 | April 30, 2024 | SAEZ, ENRIQUE | reporter.nih.gov |
| Sulfur(VI) Fluoride Exchange (SuFEx): new developments and biological applications | NIH | National Institute of General Medical Sciences | 2024 to 2025 | $1,022,000 | February 1, 2024 | November 30, 2027 | SHARPLESS, KARL BARRY | reporter.nih.gov |
| B cell lineage directed rational vaccine strategies based on CAP256SU Env-Ab coevolution | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2023 | $1,015,039 | May 4, 2022 | November 30, 2023 | ANDRABI, RAIEES AHMAD | reporter.nih.gov |
| In Vivo Incorporation of Unnatural Amino Acids | NIH | National Institute of General Medical Sciences | 2021 to 2022 | $996,526 | February 1, 2001 | November 30, 2022 | SCHULTZ, PETER G | reporter.nih.gov |
| Neuroprotective Mechanisms of S-Nitrosylated ApoE2 in Aging and Alzheimer's Disease | NIH | National Institute on Aging | 2021 to 2022 | $967,500 | September 30, 2018 | May 31, 2024 | NAKAMURA, TOMOHIRO | reporter.nih.gov |
| Targeting crotonyl-lysine chromatin readers to disrupt pathogenic gene expression in leukemia | NIH | Office of the Director, National Institutes of Health | 2021 to 2022 | $967,500 | September 7, 2018 | August 31, 2023 | ERB, MICHAEL A | reporter.nih.gov |
| Designing and optimizing candidate HIV vaccines and boosting protocols | NIH | National Institute of Allergy and Infectious Diseases | 2021 | $962,348 | November 14, 2016 | October 31, 2021 | NEMAZEE, DAVID | reporter.nih.gov |
| Novel Lassa fever live-attenuated vaccine platform with safety features ensuring unbreachable attenuation | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $959,792 | August 20, 2024 | June 30, 2028 | DE LA TORRE, JUAN C. | reporter.nih.gov |
| Molecular Basis for Regulation of Cellular Stress Response Pathways by CBP/p300 | NIH | National Cancer Institute | 2021 to 2022 | $954,783 | July 1, 2018 | June 30, 2023 | WRIGHT, PETER EDWIN | reporter.nih.gov |
| Links between rRNA and tRNA modifications, codon use, translation, and metabolism in cancer cells | NIH | National Cancer Institute | 2025 | $953,922 | September 1, 2025 | August 31, 2030 | WILLIAMSON, JAMES R | reporter.nih.gov |
| Insights into Activation Mechanisms of G Protein-Coupled and Atypical β-Arrestin-Coupled Chemokine Receptors | NIH | National Institute of General Medical Sciences | 2021 to 2022 | $921,280 | April 1, 2019 | March 31, 2024 | MILLAR, DAVID P | reporter.nih.gov |
| Predictive modeling of viral RNA cellular behavior | NIH | Office of the Director, National Institutes of Health | 2024 to 2025 | $920,000 | September 18, 2024 | July 31, 2029 | KEN, MEGAN L | reporter.nih.gov |
| Advancing HIV Vaccine Development with a Lipid Nanodisc Platform | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $910,905 | July 1, 2025 | February 12, 2026 | RANTALAINEN, KIMMO ILMARI | reporter.nih.gov |
| Restoring neuronal degradative capacity as a therapeutic strategy to treat Prion Disease | NIH | National Institute of Neurological Disorders and Stroke | 2025 | $909,090 | December 15, 2024 | November 30, 2028 | ENCALADA, SANDRA E | reporter.nih.gov |
| KLF4 in joint degradation and regeneration | NIH | National Institute on Aging | 2021 to 2022 | $907,736 | September 30, 2018 | May 31, 2025 | LOTZ, MARTIN K | reporter.nih.gov |
| Structure-based in-silico prediction of peptide interactions. | NIH | National Institute of General Medical Sciences | 2024 to 2025 | $900,000 | March 1, 2024 | February 28, 2029 | SANNER, MICHEL F. | reporter.nih.gov |
| Novel B cell epitope discovery against human coronaviruses | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $899,935 | June 10, 2025 | May 31, 2030 | WILSON, IAN A | reporter.nih.gov |
| Chemoproteomic discovery and functional analysis microbiota bile acid-protein targets in host immunity | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $891,678 | December 9, 2024 | November 30, 2029 | HANG, HOWARD C | reporter.nih.gov |
| Develop pan-specific antibody against mutant glycyl-tRNA synthetase for treating CMT2D | NIH | National Institute of Neurological Disorders and Stroke | 2022 to 2023 | $887,500 | January 1, 2021 | March 31, 2024 | YANG, XIANG-LEI | reporter.nih.gov |
| Modular synthesis of antibiotic and anticancer classes of natural products | NIH | National Institute of General Medical Sciences | 2024 to 2025 | $887,450 | August 1, 2023 | July 31, 2028 | SEIPLE, IAN BASS | reporter.nih.gov |
| Novel Hepatitis B Vaccine and Immunotherapy | NIH | National Institute of Allergy and Infectious Diseases | 2024 | $883,119 | August 21, 2024 | July 31, 2025 | LAW, MANSUN | reporter.nih.gov |
| A druggable mito-nuclear feedback mechanism that preserves mitochondrial and synaptic function in old-age | NIH | National Institute on Aging | 2025 | $878,190 | September 15, 2025 | May 31, 2030 | PETRASCHECK, MICHAEL | reporter.nih.gov |
| Pro-Electrophilic Drugs PEDs for Alzheimer's Disease | NIH | National Institute on Aging | 2021 | $876,156 | September 15, 2020 | May 31, 2024 | LIPTON, STUART A | reporter.nih.gov |
| Enantioselective and site-selective C-H activation reactions with Bifunctional ligands | NIH | National Institute of General Medical Sciences | 2025 | $874,000 | August 1, 2025 | June 30, 2030 | YU, JIN-QUAN | reporter.nih.gov |
| Activation of Neuronal Degradative Pathways to Ameliorate Prion Disease | NIH | National Institute of Neurological Disorders and Stroke | 2023 | $871,963 | July 1, 2023 | June 30, 2025 | ENCALADA, SANDRA E | reporter.nih.gov |
| Studies on Protein Lipidation | NIH | National Institute of General Medical Sciences | 2021 to 2023 | $871,671 | August 1, 2010 | June 30, 2024 | HANG, HOWARD C | reporter.nih.gov |
| Endosomal TLR transport in B cell signaling and autoimmunity | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2023 | $870,750 | February 12, 2019 | September 30, 2023 | KONO, DWIGHT H | reporter.nih.gov |
| Activation of the parasubthalamic nucleus in alcohol dependence | NIH | National Institute on Alcohol Abuse and Alcoholism | 2021 to 2022 | $870,750 | May 10, 2018 | March 31, 2024 | CONTET, CANDICE | reporter.nih.gov |
| The Genetics of Silica-Induced Autoimmunity | NIH | National Institute of Environmental Health Sciences | 2021 to 2022 | $870,750 | August 15, 2018 | December 31, 2023 | POLLARD, KENNETH MICHAEL | reporter.nih.gov |
| Pivotal role of thalamic hypocretin transmission during EtOH seeking and relapse | NIH | National Institute on Alcohol Abuse and Alcoholism | 2021 to 2022 | $870,750 | July 1, 2018 | June 30, 2024 | MARTIN-FARDON, REMI | reporter.nih.gov |
| Roles of the Nucleoprotein 3'-5' Exonuclease Domain in Arenavirus Biology | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $868,750 | April 1, 2019 | March 31, 2024 | DE LA TORRE, JUAN C. | reporter.nih.gov |
| Contributions of cell type and exosome signaling to prodromal synaptic and circuit changes in Alzheimer's Disease models | NIH | National Institute on Aging | 2025 | $848,559 | August 15, 2022 | July 31, 2027 | PETRASCHECK, MICHAEL | reporter.nih.gov |
| Development of the Next Generation of Conjugate Vaccines | NIH | National Institute of Allergy and Infectious Diseases | 2021 | $843,503 | July 25, 2018 | June 30, 2023 | TEYTON, LUC | reporter.nih.gov |
| Immunology Training | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $822,747 | July 1, 1982 | June 30, 2024 | NEMAZEE, DAVID | reporter.nih.gov |
| Development of pan-betacoronavirus vaccines | NIH | National Institute of Allergy and Infectious Diseases | 2023 | $805,612 | March 3, 2023 | June 30, 2023 | ANDRABI, RAIEES AHMAD | reporter.nih.gov |
| Initiation of anti-islet autoimmunity: Regulation of MHC class II expression in the islet microenvironment | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2025 | $801,662 | August 15, 2025 | June 30, 2029 | TEYTON, LUC | reporter.nih.gov |
| Investigating the chromatin remodeling functions of polyphosphate condensates in Pseudomonas aeruginosa | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $779,915 | May 5, 2025 | April 30, 2030 | RACKI, LISA R | reporter.nih.gov |
| Mechanisms of Protection of Universal Therapeutic Antibodies to Influenza A | NIH | National Institute of Allergy and Infectious Diseases | 2021 | $773,720 | January 1, 2019 | December 31, 2023 | PAUST, SILKE | reporter.nih.gov |
| HIV antibodies and NK cell ADCC: nanometer-scale tracking of immune synapse dynamics. | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $767,184 | September 17, 2021 | March 31, 2023 | MURIN, CHARLES DANIEL | reporter.nih.gov |
| PTPN22 R619W in NOD mice | NIH | National Institute of Allergy and Infectious Diseases | 2021 | $745,163 | June 1, 2017 | May 31, 2022 | SHERMAN, LINDA A | reporter.nih.gov |
| Biology of α-linked glycosylceramides in the immune system | NIH | National Institute of Allergy and Infectious Diseases | 2021 | $723,259 | January 2, 2017 | December 31, 2022 | TEYTON, LUC | reporter.nih.gov |
| A Unique Class of Reductively Activated Oncology Drugs | NIH | National Cancer Institute | 2021 | $718,986 | March 14, 2017 | February 28, 2023 | BOGER, DALE L | reporter.nih.gov |
| Control of opioid-motivated approach and avoidance behavior by neuronal ensembles in the basolateral amygdala and their projection targets in the nucleus accumbens | NIH | National Institute on Drug Abuse | 2022 to 2025 | $713,889 | September 1, 2022 | August 31, 2027 | NEDELESCU, HERMINA | reporter.nih.gov |
| Defining Endoplasmic Reticulum Stress-Development Mitochondria Remodeling | NIH | National Institute of Neurological Disorders and Stroke | 2025 | $684,451 | August 20, 2022 | June 30, 2027 | WISEMAN, ROCKLAND LUKE | reporter.nih.gov |
| Role of BK channels in alcohol-induced dysmyelination | NIH | National Institute on Alcohol Abuse and Alcoholism | 2025 | $657,156 | September 1, 2025 | May 31, 2030 | CONTET, CANDICE | reporter.nih.gov |
| Combinatorial, Catalytic Functionalization of Alkenes and Alkynes | NIH | National Institute of General Medical Sciences | 2021 | $655,942 | August 1, 2017 | July 31, 2022 | ENGLE, KEARY MARK | reporter.nih.gov |
| Early diagnosis and mechanistic studies of type 1 diabetes using single cell analysis | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2024 to 2025 | $653,246 | March 15, 2019 | June 30, 2027 | TEYTON, LUC | reporter.nih.gov |
| S-Nitrosylation-Induced Posttranslational Modification and Aberrant Cell Signaling in Sporadic Alzheimer's Disease | NIH | National Institute on Aging | 2021 | $651,737 | September 30, 2017 | May 31, 2024 | LIPTON, STUART A | reporter.nih.gov |
| Rational design and B cell responses of HIV epitope vaccines | NIH | National Institute of Allergy and Infectious Diseases | 2021 | $638,644 | November 1, 2016 | October 31, 2022 | ZHU, JIANG | reporter.nih.gov |
| Stress modulation of olfactory sensation | NIH | National Institute on Deafness and Other Communication Disorders | 2021 | $634,986 | December 1, 2016 | November 30, 2021 | STOWERS, LISA | reporter.nih.gov |
| Data Mining and Functional Validation of SCORCH Datasets | NIH | National Institute on Drug Abuse | 2025 | $608,652 | September 1, 2025 | May 31, 2030 | SANNA, PIETRO P | reporter.nih.gov |
| Exploring Routes to Homochirality in the Synthesis of Biological Polymers | NSF | Chemistry Section | 2025 | $602,976 | September 1, 2025 | August 31, 2028 | Donna G Blackmond | nsf.gov |
| High-speed direct detector for cryo electron microscopy | NIH | Office of the Director, National Institutes of Health | 2022 | $600,000 | March 1, 2022 | February 28, 2023 | LANDER, GABRIEL C | reporter.nih.gov |
| Molecular basis for regulation of CREB by cell stress and retroviral oncoproteins | NIH | National Cancer Institute | 2021 | $599,187 | December 5, 2016 | November 30, 2022 | WRIGHT, PETER EDWIN | reporter.nih.gov |
| Accelerating Discovery by Merging Kinetics with Data Science Methods in Catalytic Organic Reactions | NIH | National Institute of General Medical Sciences | 2025 | $582,422 | August 1, 2025 | July 31, 2030 | BLACKMOND, DONNA G | reporter.nih.gov |
| Synthetic and Mechanistic Studies of Nickel-Catalyzed 1,2-Dicarbofunctionalization of Alkenes | NSF | Chemistry Section | 2024 | $575,000 | July 1, 2024 | June 30, 2027 | Keary M Engle | nsf.gov |
| Bifunctional Catalysts for MHAT Hydrofunctionalization of Alkenes | NSF | Chemistry Section | 2024 | $574,995 | August 1, 2024 | July 31, 2027 | Ryan Shenvi | nsf.gov |
| Expedient Synthesis of Glycosaminoglycan Saccharides with Defined Sulfation Patterns for Probing Human Protein Interactions. | NSF | Chemistry Section | 2026 | $552,000 | September 1, 2026 | August 31, 2029 | Chi-Huey Wong | nsf.gov |
| Computer-aided Synthesis and Diversification of a Selective SQR Inhibitor | NSF | Chemistry Section | 2025 | $549,996 | September 1, 2025 | August 31, 2028 | Ryan Shenvi | nsf.gov |
| Attached-Ring Cross-Coupling to Explore Chemical Space and Receptor Selectivity | NSF | Division Of Chemistry | 2022 | $525,000 | August 1, 2022 | July 31, 2025 | Ryan Shenvi | nsf.gov |
| Controlled Catalytic Functionalization of Alkenes and Alkynes | NIH | National Institute of General Medical Sciences | 2025 | $524,400 | June 1, 2025 | April 30, 2030 | ENGLE, KEARY MARK | reporter.nih.gov |
| Proof-of-Concept Human Laboratory Testing of Novel Drug Candidates Identified by INIA-NeuroImmune | NIH | National Institute on Alcohol Abuse and Alcoholism | 2021 | $522,391 | February 1, 2017 | January 31, 2022 | MASON, BARBARA J | reporter.nih.gov |
| Gene Wiki: A community-maintained knowledge base of biomedical information | NIH | National Institute of General Medical Sciences | 2021 | $517,363 | August 1, 2010 | March 31, 2023 | SU, ANDREW I | reporter.nih.gov |
| Immunotherapy to Counteract Lethal Doses of Carfentanil | NIH | National Institute on Drug Abuse | 2021 | $516,902 | February 1, 2019 | April 30, 2022 | JANDA, KIM | reporter.nih.gov |
| CTSA Postdoctoral T32 at The Scripps Research Institute | NIH | National Center for Advancing Translational Sciences | 2024 to 2025 | $511,478 | August 5, 2024 | July 31, 2029 | LAMIA, KATJA A | reporter.nih.gov |
| Developing graphene grids to overcome air-water-interface issues | NIH | National Institute of General Medical Sciences | 2024 to 2025 | $506,000 | September 15, 2024 | August 31, 2026 | GROTJAHN, DANIELLE ANN | reporter.nih.gov |
| Modulation of host immunity with recombinant peptidoglycan hydrolases | NIH | National Center for Complementary & Integrative Health | 2024 | $506,000 | September 13, 2024 | August 31, 2026 | HANG, HOWARD C | reporter.nih.gov |
| Development of potent and safe CRISPR tools for in vivo gene editing using directed evolution | NIH | National Institute of Biomedical Imaging and Bioengineering | 2024 to 2025 | $506,000 | May 3, 2024 | April 30, 2027 | MILLER, SHANNON MARIE | reporter.nih.gov |
| Mechanistic Investigation of the Role of FBXW7 in Inflammasome Activation | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $506,000 | June 17, 2024 | April 30, 2026 | REED, STEVEN I | reporter.nih.gov |
| A novel model of severe inflammatory arthritis induced by pulmonary silica exposure | NIH | National Institute of Environmental Health Sciences | 2024 to 2025 | $506,000 | August 20, 2024 | July 31, 2026 | POLLARD, KENNETH MICHAEL | reporter.nih.gov |
| Preparation and Investigation of Monoclonal Antibodies to Block Xylazine's Mechanism of Action and Adverse Effects | NIH | National Institute on Drug Abuse | 2025 | $506,000 | July 15, 2025 | June 30, 2027 | JANDA, KIM | reporter.nih.gov |
| Engineering Synthetic Biomolecular Condensates for Targeted Autophagy Modulation | NIH | National Institute on Aging | 2025 | $506,000 | August 15, 2025 | July 31, 2027 | LASKER, KEREN | reporter.nih.gov |
| Mechanisms of ATAD3A in Regulating the Mitochondrial Genome | NIH | National Institute of Neurological Disorders and Stroke | 2025 | $506,000 | August 1, 2025 | July 31, 2027 | GROTJAHN, DANIELLE ANN | reporter.nih.gov |
| Development of siRNA-peptide libraries for delivery screening | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $506,000 | July 9, 2025 | June 30, 2027 | MACRAE, IAN JOHN | reporter.nih.gov |
| Defining the structure-interactome relationships of the basigin glycoprotein in endometriosis | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2025 | $506,000 | August 1, 2025 | July 31, 2027 | HUANG, MIA L | reporter.nih.gov |
| An Enzyme-Based Antidote for Acute Nicotine Toxicity | NIH | National Institute on Drug Abuse | 2023 to 2024 | $501,500 | September 30, 2023 | August 31, 2025 | JANDA, KIM | reporter.nih.gov |
| Cocaine-motivated behaviors: development of novel viral-based strategies to target orexinergic input to the infralimbic cortex. | NIH | National Institute on Drug Abuse | 2022 to 2023 | $501,228 | August 1, 2022 | July 31, 2025 | MARTIN-FARDON, REMI | reporter.nih.gov |
| Lifespan extension by reverse fasting | NIH | National Institute on Aging | 2023 to 2024 | $497,750 | March 1, 2023 | December 31, 2024 | PETRASCHECK, MICHAEL | reporter.nih.gov |
| Initiation of HIV Capsid Assembly Monitored by Mass Photometry | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2024 | $497,750 | January 13, 2023 | December 31, 2024 | WILLIAMSON, JAMES R | reporter.nih.gov |
| Removing sialic acid ligands of CD28 to enhance T cell cancer immunotherapy | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2024 | $497,750 | February 17, 2023 | January 31, 2025 | PAULSON, JAMES C | reporter.nih.gov |
| Collaborative Cross Strains as Models of Systemic Autoimmunity | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2024 | $497,750 | June 16, 2023 | May 31, 2025 | POLLARD, KENNETH MICHAEL | reporter.nih.gov |
| Elucidation of the interactome for the bioactive disaccharide Man(B1-4)GlcNAc | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $494,600 | January 8, 2024 | November 30, 2025 | HUANG, MIA L | reporter.nih.gov |
| High Throughput Methods for Single Cell Proteomics | NIH | National Institute of Mental Health | 2022 to 2023 | $492,500 | May 1, 2022 | April 30, 2025 | YATES III, JOHN R | reporter.nih.gov |
| Mapping glycan-dependent neurexin interactomes | NIH | National Institute of Neurological Disorders and Stroke | 2022 to 2023 | $491,625 | August 15, 2022 | July 31, 2024 | HUANG, MIA L | reporter.nih.gov |
| Distal gut microbiome targets of host anti-proteolytic proteins during colitis | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $488,125 | December 18, 2020 | November 30, 2022 | HANG, HOWARD C | reporter.nih.gov |
| Do allergens contribute to neurodegeneration? | NIH | National Institute of Neurological Disorders and Stroke | 2021 | $488,125 | May 1, 2021 | January 31, 2022 | CONTI, BRUNO | reporter.nih.gov |
| Predicting Short- and Long-term Future Occurrence of Atrial Fibrillation from Single-Lead ECG in Normal Sinus Rhythm with an Explainable Deep Learning Model. | NIH | National Institute on Aging | 2021 to 2022 | $488,125 | July 1, 2021 | March 31, 2024 | QUER, GIORGIO | reporter.nih.gov |
| JAML-CAR regulation of adipose tissue homeostasis | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $488,125 | February 9, 2021 | January 31, 2024 | MCKAY, DIANNE B | reporter.nih.gov |
| TRAPping loss of control in binge eating | NIH | National Institute of Mental Health | 2021 to 2022 | $488,125 | May 1, 2021 | October 31, 2023 | ZORRILLA, ERIC P | reporter.nih.gov |
| Development of a pipeline for parallel elucidation of protein structures | NIH | National Institute of General Medical Sciences | 2021 to 2022 | $488,125 | July 1, 2021 | June 30, 2023 | LANDER, GABRIEL C | reporter.nih.gov |
| Discovering modulators of exonucleases PLD3 and PLD4 for immunoregulation | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2023 | $488,125 | May 10, 2022 | October 31, 2024 | JANDA, KIM | reporter.nih.gov |
| Modulation of in vivo MAIT cell responses with diverse MR1 ligands | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2023 | $488,125 | May 24, 2022 | April 30, 2024 | CONSTANTINIDES, MICHAEL GEORGE | reporter.nih.gov |
| Designing mammarenavirus live vaccines with unbreachable attenuation | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2023 | $488,125 | July 12, 2022 | June 30, 2024 | DE LA TORRE, JUAN C. | reporter.nih.gov |
| CHEMOPROTEOMIC METHODS FOR SERINE HYDROLASE INHIBITOR DEVELOPMENT | NIH | National Institute on Drug Abuse | 2021 | $486,911 | April 1, 2012 | March 31, 2022 | CRAVATT, BENJAMIN F | reporter.nih.gov |
| BioGPS, BioThings and BioReel: illuminating dark data for biomedical research | NIH | National Institute of General Medical Sciences | 2021 | $483,750 | August 1, 2008 | March 31, 2023 | WU, CHUNLEI | reporter.nih.gov |
| Managing the Folding Landscape in Alpha1 Liver-Lung Disease | NIH | National Heart, Lung, and Blood Institute | 2021 | $483,750 | July 15, 2018 | April 30, 2023 | BALCH, WILLIAM EDWARD | reporter.nih.gov |
| Analyses of the Antiviral and Antifibrotic Mechanisms of Action of NS5A and Cyclophilin Inhibitors | NIH | National Institute of Allergy and Infectious Diseases | 2021 | $481,250 | January 16, 2017 | December 31, 2022 | GALLAY, PHILIPPE ANDRE | reporter.nih.gov |
| 3D Proteomics at Single Cell Resolution with Covalent Protein Painting (CPP) | NIH | National Cancer Institute | 2024 to 2025 | $480,092 | August 14, 2024 | July 31, 2027 | YATES III, JOHN R | reporter.nih.gov |
| PPARdelta receptors and alcohol use phenotypes | NIH | National Institute on Alcohol Abuse and Alcoholism | 2023 to 2024 | $479,438 | May 1, 2023 | April 30, 2025 | ZORRILLA, ERIC P | reporter.nih.gov |
| Role of glucocorticoid receptor-mediated mRNA decay in alcohol dependence | NIH | National Institute on Alcohol Abuse and Alcoholism | 2023 to 2024 | $477,775 | September 20, 2023 | August 31, 2025 | CONTET, CANDICE | reporter.nih.gov |
| Deconvolution of Galbulimima bark pharmacology through chemical synthesis and target assignment | NIH | National Center for Complementary & Integrative Health | 2022 | $470,533 | September 26, 2022 | June 7, 2023 | SHENVI, RYAN ASHOK | reporter.nih.gov |
| NRSA Training Core | NIH | National Center for Advancing Translational Sciences | 2021 to 2022 | $464,346 | May 1, 2018 | July 31, 2024 | TEYTON, LUC | reporter.nih.gov |
| REU Site: Scripps Structure and Function Summer Institute (SFSI) | NSF | Infrastructure, Institutes, & Centers | 2026 | $458,766 | May 1, 2026 | April 30, 2029 | Keary M Engle | nsf.gov |
| "Extended dosing" immunization to enhance humoral immunity to next-generation vaccines | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $454,147 | February 14, 2023 | January 31, 2028 | IRVINE, DARRELL J | reporter.nih.gov |
| Role of PLD3 in nucleic acid recognition and brain function | NIH | National Institute on Aging | 2025 | $450,798 | August 15, 2022 | July 31, 2027 | HANG, HOWARD C | reporter.nih.gov |
| Developing minimal purification cryo-EM to understand mitochondrial myopathies | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2023 | $444,109 | September 1, 2023 | August 31, 2025 | LANDER, GABRIEL C | reporter.nih.gov |
| Role of PLD3 in nucleic acid recognition and brain function | NIH | National Institute on Aging | 2021 | $443,750 | May 15, 2021 | April 30, 2022 | NEMAZEE, DAVID | reporter.nih.gov |
| Functional Interrogation Of Ribosomal Biology Using Continuous Evolution | NIH | Office of the Director, National Institutes of Health | 2021 | $443,750 | September 1, 2021 | November 30, 2022 | BADRAN, AHMED HUSSEIN | reporter.nih.gov |
| REU Site: Scripps Structure and Function Summer Institute (SFSI) | NSF | Infrastructure, Institutes, & Centers | 2022 | $441,471 | June 15, 2022 | May 31, 2026 | Philip E Dawson | nsf.gov |
| Develop pan-specific antibody against mutant glycyl-tRNA synthetase for treating CMT2D | NIH | National Institute of Neurological Disorders and Stroke | 2021 | $431,350 | January 1, 2021 | December 31, 2021 | YANG, XIANG-LEI | reporter.nih.gov |
| Explore the involvement of tRNA in the pathophysiology of antisynthetase syndrome | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2024 to 2025 | $425,040 | August 15, 2024 | July 31, 2026 | YANG, XIANG-LEI | reporter.nih.gov |
| Illuminating Galectin-3 Interactions to Disrupt Hepatic Fibrosis | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 | $423,185 | August 1, 2021 | September 30, 2022 | HUANG, MIA L | reporter.nih.gov |
| A chemical biology-based approach to the study of FOXP3 and Regulatory T Cell Fate | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $417,984 | March 7, 2025 | February 28, 2026 | LAIRSON, LUKE LEE | reporter.nih.gov |
| Regulation of exercise physiology by mammalian cryptochromes | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 | $416,667 | December 7, 2017 | November 30, 2021 | LAMIA, KATJA A | reporter.nih.gov |
| Dynamic modulation of p53 activity by its disordered regulatory domains | NIH | National Institute of General Medical Sciences | 2021 | $414,512 | April 1, 2006 | March 31, 2023 | WRIGHT, PETER EDWIN | reporter.nih.gov |
| The role of microRNAs in cartilage homeostasis and osteoarthritis arthritis treatment | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 | $410,795 | July 1, 2004 | June 30, 2022 | ASAHARA, HIROSHI | reporter.nih.gov |
| Exploring a new arm of the integrated stress response and its connection to neurodegeneration | NIH | National Institute of Neurological Disorders and Stroke | 2021 | $410,563 | July 1, 2021 | December 31, 2022 | YANG, XIANG-LEI | reporter.nih.gov |
| Scripps Research Translational Chemical Biology | NIH | National Institute of General Medical Sciences | 2025 | $404,450 | August 11, 2025 | June 30, 2030 | HUANG, MIA L | reporter.nih.gov |
| Stablization of Fragile Human Transfer RNAs | NIH | National Institute of General Medical Sciences | 2021 | $387,000 | August 23, 2018 | June 30, 2022 | SCHIMMEL, PAUL R | reporter.nih.gov |
| TLR Transporters in Lupus | NIH | National Institute of Allergy and Infectious Diseases | 2021 | $387,000 | August 28, 2018 | July 31, 2022 | KONO, DWIGHT H | reporter.nih.gov |
| Molecular mechanisms of autophagosome biogenesis | NIH | National Institute of General Medical Sciences | 2021 | $380,837 | December 1, 2010 | December 31, 2021 | OTOMO, TAKANORI | reporter.nih.gov |
| Innate Immune Surveillance of HIV-1 During Transmission and Systemic Infection | NIH | National Institute of Allergy and Infectious Diseases | 2021 | $379,532 | February 28, 2017 | January 31, 2023 | CHANDA, SUMIT K | reporter.nih.gov |
| Experimentally Testing the Endosymbiotic Theory of Mitochondrial Evolution | NIH | National Institute of General Medical Sciences | 2021 | $377,325 | April 1, 2019 | March 31, 2022 | SCHULTZ, PETER G | reporter.nih.gov |
| Epigenetic regulation of alcohol tolerance and dependence by methyl CpG binding protein 2 | NIH | National Institute on Alcohol Abuse and Alcoholism | 2021 | $362,813 | June 1, 2017 | May 31, 2022 | SANNA, PIETRO P | reporter.nih.gov |
| Extended amygdala somatostatin role in post-traumatic stress and alcohol use disorder | NIH | National Institute on Alcohol Abuse and Alcoholism | 2024 to 2025 | $360,720 | September 1, 2024 | March 9, 2026 | CRUZ, BRYAN | reporter.nih.gov |
| The Role of Endocannabinoids in Adulthood Alcohol Drinking After Adolescent Social Isolation | NIH | National Institute on Alcohol Abuse and Alcoholism | 2023 to 2024 | $352,296 | July 15, 2023 | September 30, 2024 | VOZELLA, VALENTINA | reporter.nih.gov |
| Early development of small molecule dendritic cell immunopotentiators for the treatment of solid tumors | NIH | National Cancer Institute | 2021 | $343,138 | July 11, 2018 | June 30, 2023 | YOH, SUNNIE | reporter.nih.gov |
| Discovering and Characterizing Druggable Cysteines in Cancer Dependency Proteins | NIH | National Cancer Institute | 2024 to 2025 | $331,560 | April 2, 2024 | March 31, 2027 | LI, HAOXIN | reporter.nih.gov |
| Transcriptional adaptations driving the intensification of alcohol-seeking in dependent rats undergoing prolonged abstinence | NIH | National Institute on Alcohol Abuse and Alcoholism | 2022 to 2023 | $329,745 | August 18, 2022 | April 26, 2024 | SUTO, NOBUYOSHI | reporter.nih.gov |
| An Innovative Approach to Identify Correctors of Metabolic Complications in HIV | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 | $319,391 | September 1, 2021 | August 31, 2023 | SANNA, PIETRO P | reporter.nih.gov |
| Deconstructing brainstem circuits for visceral senses | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2024 to 2025 | $306,720 | July 1, 2023 | April 30, 2028 | RAN, CHEN | reporter.nih.gov |
| Control of HIV-induced MDSC expansion and immunosuppression by cytotoxic lymphocytes | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2023 | $301,695 | August 1, 2022 | August 25, 2023 | PAUST, SILKE | reporter.nih.gov |
| Addiction Training in Discovery, Computation, and Translation to Medicine | NIH | National Institute on Drug Abuse | 2025 | $288,107 | July 1, 2025 | June 30, 2030 | ZORRILLA, ERIC P | reporter.nih.gov |
| Expanding BioThings as a community API gateway for sharing biomedical knowledge | NIH | National Library of Medicine | 2025 | $276,000 | September 1, 2025 | August 31, 2027 | WU, CHUNLEI | reporter.nih.gov |
| Neural activity-based candidate gene identification to link eating disorders and drug addiction | NIH | National Institute on Drug Abuse | 2023 | $271,500 | July 1, 2023 | June 30, 2024 | SUTO, NOBUYOSHI | reporter.nih.gov |
| Crosstalk between MAIT cells and the microbiota | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $270,000 | May 14, 2021 | April 30, 2023 | CONSTANTINIDES, MICHAEL GEORGE | reporter.nih.gov |
| Extending the limits of cryo-EM to better understand TTR misfolding and aggregation | NIH | National Institute on Aging | 2021 | $266,250 | September 15, 2020 | May 31, 2022 | LANDER, GABRIEL C | reporter.nih.gov |
| Role of selective autophagy in aging and neurodegeneration: a small molecule approach | NIH | National Institute on Aging | 2023 to 2024 | $252,500 | February 15, 2023 | January 31, 2026 | TAN, EE PHIE | reporter.nih.gov |
| The Molecular Basis of PIEZO Ion Channel Function | NIH | National Institute of General Medical Sciences | 2024 to 2025 | $250,000 | August 1, 2024 | July 31, 2026 | MULHALL, ERIC MICHAEL | reporter.nih.gov |
| Rheumatoid factor and cryoglobulinemia in chronic viral infection | NIH | National Institute of Allergy and Infectious Diseases | 2021 | $241,875 | December 18, 2019 | November 30, 2022 | LAW, MANSUN | reporter.nih.gov |
| Extrahypothalamic PPARs and compulsive food intake | NIH | National Institute on Drug Abuse | 2021 | $241,875 | January 1, 2020 | June 30, 2023 | ZORRILLA, ERIC P | reporter.nih.gov |
| Epoxide metabolism as a modulator of aging | NIH | National Institute on Aging | 2021 | $241,875 | January 1, 2020 | June 30, 2022 | PETRASCHECK, MICHAEL | reporter.nih.gov |
| Functional interrogation of sensory neurons in inflammation | NIH | National Institute of Neurological Disorders and Stroke | 2023 to 2024 | $239,760 | August 1, 2023 | July 31, 2025 | HILL, ROSE Z | reporter.nih.gov |
| Germline targeting for neuraminidase broadly neutralizing antibodies | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $230,000 | January 23, 2025 | December 31, 2026 | STEICHEN, JON | reporter.nih.gov |
| Adaptations to chronic activation of BK channels by ethanol: Contribution to dependence and tolerance | NIH | National Institute on Alcohol Abuse and Alcoholism | 2021 | $225,932 | January 15, 2020 | September 9, 2022 | CONTET, CANDICE | reporter.nih.gov |
| Brain-wide functional mapping of circuits controlling hedonic feeding in obesity | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 | $225,666 | July 1, 2017 | December 31, 2022 | YE, LI | reporter.nih.gov |
| Modeling xenobiotic-induced autoimmunity using Collaborative Cross strains. | NIH | National Institute of Environmental Health Sciences | 2021 | $221,875 | March 1, 2020 | February 28, 2022 | POLLARD, KENNETH MICHAEL | reporter.nih.gov |
| Directed Evolution of HIV Broadly Neutralizing Antibodies Using a Novel CRISPR-Engineered B cell in Vitro Affinity Maturation Platform | NIH | National Institute of Allergy and Infectious Diseases | 2021 | $221,875 | March 1, 2020 | February 28, 2023 | VOSS, JAMES EVEN | reporter.nih.gov |
| Purifying Membrane Proteins within Native Lipid Bilayers | NIH | National Institute of General Medical Sciences | 2021 | $221,875 | April 1, 2020 | March 31, 2022 | ZHANG, QINGHAI | reporter.nih.gov |
| AIM2 as a negative regulator of renal ischemia/reperfusion injury | NIH | National Institute of Allergy and Infectious Diseases | 2021 | $221,875 | May 22, 2020 | April 30, 2023 | MCKAY, DIANNE B | reporter.nih.gov |
| Mouse models for decoding microRNA regulation in diverse tissues and cell types | NIH | Office of the Director, National Institutes of Health | 2021 | $221,875 | July 15, 2021 | June 30, 2022 | MACRAE, IAN JOHN | reporter.nih.gov |
| Distinguishing plasminogen-dependent and plasminogen-independent roles of the plasminogen receptor, Plg-RKT | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 | $221,875 | July 19, 2020 | December 31, 2022 | MILES, LINDSEY A | reporter.nih.gov |
| Defining Structural and Molecular Mechanisms of The Human Multifunctional Mitochondrial Protease, LONP1 | NIH | National Institute of General Medical Sciences | 2022 to 2024 | $216,430 | January 3, 2022 | January 2, 2025 | MINDREBO, JEFFREY TODD | reporter.nih.gov |
| Examining the Role of Circulating Endocannabinoids in Predicting Alcohol Relapse Risk and Resiliency | NIH | National Institute on Alcohol Abuse and Alcoholism | 2021 | $210,781 | April 10, 2020 | March 31, 2023 | MASON, BARBARA J | reporter.nih.gov |
| Development of selective chemical tools to investigate sialyltransferases and sialoside products | NIH | National Institute of General Medical Sciences | 2021 | $208,625 | April 1, 2020 | March 31, 2022 | NYCHOLAT, CORWIN MICHAEL | reporter.nih.gov |
| Novel circuit mechanism of alcohol dependence vulnerability following early-life adversity | NIH | National Institute on Alcohol Abuse and Alcoholism | 2021 | $206,728 | August 10, 2020 | July 31, 2023 | CONTET, CANDICE | reporter.nih.gov |
| Stereoisomeric chemical probes for targeting undruggable oncoproteins | NIH | National Cancer Institute | 2021 to 2023 | $205,368 | September 1, 2021 | August 31, 2024 | REINHARDT, CHRISTOPHER JOHN | reporter.nih.gov |
| Generation of Chimeric DNA-RNA Structures using Engineered Replisomes in vivo | NIH | National Institute of General Medical Sciences | 2021 to 2023 | $202,284 | September 1, 2021 | August 31, 2024 | SANDOVAL, BRADDOCK | reporter.nih.gov |
| Discovery of metabolic pathways using phenotypic screening and chemical proteomics | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2023 to 2025 | $197,399 | July 1, 2023 | January 26, 2026 | JARIWALA, PARTH BALVANT | reporter.nih.gov |
| Role of parasubthalamic astrocytic dysfunction in alcohol use disorder | NIH | National Institute on Alcohol Abuse and Alcoholism | 2024 to 2025 | $181,753 | February 1, 2023 | January 31, 2028 | WHITE, ALLISON | reporter.nih.gov |
| How does mechanosensation contribute to choroid plexus function in health and disease? | NIH | National Institute of Neurological Disorders and Stroke | 2024 to 2025 | $152,324 | May 1, 2024 | April 30, 2027 | PROFACI, CATERINA P | reporter.nih.gov |
| Characterization of TMEM164 as novel multi-pass transmembrane enzyme and its role in ferroptosis | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2023 to 2024 | $146,256 | July 1, 2023 | June 30, 2025 | WARE, TIMOTHY BRANDON | reporter.nih.gov |
| Investigating Cancer-Specific Long Noncoding RNAs for Early Cancer Detection | NIH | National Cancer Institute | 2021 | $144,678 | September 20, 2019 | July 5, 2022 | HART, JONATHAN ROSS | reporter.nih.gov |
| Pd-Catalyzed C(sp3)-H Functionalizations Directed by Free Alcohols and Boc-Protected Amines | NIH | National Institute of General Medical Sciences | 2022 to 2023 | $136,674 | May 1, 2022 | April 30, 2024 | STRASSFELD, DANIEL AARON | reporter.nih.gov |
| Quantitation of Bacterial Proteome Composition under Oxygen-limiting and Slow Growth Conditions | NIH | National Institute of General Medical Sciences | 2021 to 2022 | $136,192 | June 15, 2021 | June 14, 2023 | ABDOLLAH NIA, MOHAMMAD FARSHAD | reporter.nih.gov |
| Chemical mapping of protein networks that sense cellular force | NIH | National Institute of General Medical Sciences | 2021 to 2022 | $133,576 | April 5, 2021 | April 4, 2023 | KOSTER, ANNA KATHERINE | reporter.nih.gov |
| Feeding regulation by cortical-amygdala circuits | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 | $133,125 | April 1, 2020 | March 31, 2023 | YE, LI | reporter.nih.gov |
| Functional interrogation of the role of PTP1B in Alzheimer's disease pathophysiology and sleep | NIH | National Institute on Aging | 2024 | $132,300 | May 1, 2024 | April 30, 2025 | LY, SARAH | reporter.nih.gov |
| Discovery of small molecule-mediated protein degradation pathways in human cancer | NIH | National Cancer Institute | 2021 | $123,655 | May 1, 2020 | January 31, 2022 | ZHANG, XIAOYU | reporter.nih.gov |
| Discovering miRNA-Mediated Mechanisms of Interneuron Development | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2023 | $123,571 | September 1, 2021 | August 31, 2024 | DU, JESSICA XINYUN | reporter.nih.gov |
| Proteomic discovery and characterization of chemical tools that degrade the NuRD chromatin regulatory complex | NIH | National Institute of General Medical Sciences | 2021 to 2022 | $116,908 | January 1, 2021 | August 31, 2022 | REMILLARD, DAVID IAN | reporter.nih.gov |
| Inhibiting biomechanical platelet aggregation to prevent arterial thrombosis without compromising hemostasis | NIH | National Heart, Lung, and Blood Institute | 2021 | $101,177 | September 21, 2020 | March 31, 2022 | CHEN, YUNFENG | reporter.nih.gov |
| Amplifications and signaling of oncoproteins in cancer | NIH | National Cancer Institute | 2025 | $96,120 | January 1, 2025 | December 31, 2025 | HUNG, KING L. | reporter.nih.gov |
| A universal high-throughput platform to improve biological functions of small molecules | NIH | National Institute of General Medical Sciences | 2021 | $95,777 | August 1, 2020 | April 30, 2022 | KITAMURA, SEIYA | reporter.nih.gov |
| Molecular mechanisms of mechanosensing in the urinary tract | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 | $91,445 | May 1, 2021 | April 30, 2022 | MARSHALL, KARA L | reporter.nih.gov |
| The Development of Organelle Specific Hsp90 Isoform-Selective Inhibitors | NIH | National Cancer Institute | 2021 | $85,399 | January 1, 2018 | August 31, 2021 | CROWLEY, VINCENT | reporter.nih.gov |
| Molecular mechanism of PIN1-mediated regulation of the nuclear receptor PPARy | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2023 to 2025 | $80,426 | March 1, 2023 | April 27, 2025 | WILLIAMS, CHRISTOPHER CONRAD | reporter.nih.gov |
| SMAC Mimetics as Broad-Spectrum Antivirals | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $75,520 | September 15, 2025 | November 14, 2026 | DUGGAN, NATASHA NOTANDO | reporter.nih.gov |
| Elucidation of the Mechanism of Microhomology-Mediated End Joining by DNA Polymerase Theta | NIH | National Cancer Institute | 2024 | $74,284 | March 26, 2024 | March 25, 2025 | ZERIO, CHRISTOPHER JOHN | reporter.nih.gov |
| Investigating the mechanism of decision-making in the mitochondrial Protease YME1 | NIH | National Institute of Neurological Disorders and Stroke | 2024 to 2025 | $72,512 | January 16, 2024 | January 15, 2026 | ALEXANDRESCU, LAUREN | reporter.nih.gov |
| Development of soluble and membrane bound immunogens to shepherd HIV-1 MPER specific BCR maturation | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $72,512 | August 2, 2024 | August 1, 2027 | SWANSON, OLIVIA | reporter.nih.gov |
| Alleviating Mitochondrial Dysfunction in PERK-deficient Neurodegenerative Disease | NIH | National Institute on Aging | 2023 to 2024 | $70,668 | April 1, 2023 | March 31, 2027 | BARON, KELSEY ROSE | reporter.nih.gov |
| Investigating the pathomechanisms underlying Charcot-Marie-Tooth Disease | NIH | National Institute of Neurological Disorders and Stroke | 2022 to 2023 | $70,446 | July 1, 2022 | June 30, 2024 | JONES, JULIA ALEXIS | reporter.nih.gov |
| Small molecule modulation of 14-3-3 protein-protein interactions | NIH | National Cancer Institute | 2023 | $68,684 | July 1, 2023 | June 30, 2024 | TING, STEPHEN I | reporter.nih.gov |
| Allosteric Pharmacologic Chaperones for alpha-1 Antitrypsin Mutants | NIH | National Institute of General Medical Sciences | 2022 to 2023 | $68,446 | February 1, 2022 | January 31, 2024 | GUERRERO, ADRIAN M. | reporter.nih.gov |
| Defining the Allosteric Network of Stress-Responsive Mitochondrial Protease OMA1 | NIH | National Institute on Aging | 2021 to 2022 | $66,788 | February 1, 2021 | May 31, 2022 | SONG, ALBERT SANGHOON | reporter.nih.gov |
| Defining molecular and cellular mechanisms of protection from malaria infection by PfCSP-targeting antibodies | NIH | National Institute of Allergy and Infectious Diseases | 2021 | $66,390 | June 15, 2021 | June 14, 2022 | MARTIN, GREGORY M | reporter.nih.gov |
| Manipulating microRNA-target interactions to rescue protein levels in haploinsufficient disorders | NIH | National Institute of Neurological Disorders and Stroke | 2025 | $45,982 | June 1, 2025 | May 31, 2028 | SIEVERT, DAVID | reporter.nih.gov |
| Alcoholism and Stress: A Framework for Future Treatment Strategies | NIH | National Institute on Alcohol Abuse and Alcoholism | 2021 to 2022 | $45,001 | March 1, 2008 | August 31, 2025 | ROBERTO, MARISA | reporter.nih.gov |
| PQBP1 as a central regulator of inflammation in neurodegenerative diseases | NIH | National Institute of Neurological Disorders and Stroke | 2025 | $36,538 | February 1, 2025 | January 31, 2029 | ALLEN, DALE S | reporter.nih.gov |
| Leveraging in vivo protein tracking to identify novel immune markers associated with obesity driven disease | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2025 | $36,538 | May 16, 2025 | May 15, 2028 | BANKI, MICHAEL ARIAN | reporter.nih.gov |
| Potent and specific small molecule stabilizers of amyloidogenic antibody light chains | NIH | National Heart, Lung, and Blood Institute | 2022 | $33,752 | December 1, 2020 | November 30, 2022 | YAN, NICHOLAS | reporter.nih.gov |
| Evaluation of structural conservation and glycan-mediated host receptor engagement of pan-lineage Lassa fusion glycoproteins by cryo-EM | NIH | National Institute of Allergy and Infectious Diseases | 2022 | $33,752 | September 1, 2022 | August 31, 2023 | PERRETT, HAILEE ROSE | reporter.nih.gov |
| Elucidating the mechanisms of CDK inhibitor resistance in cancer using chemical proteomics | NIH | National Cancer Institute | 2021 | $33,036 | April 1, 2019 | March 31, 2022 | KEMPER, ESTHER KIM | reporter.nih.gov |
| The SRBR 2022 Meeting: Rhythms of Life - from Molecules to Policy | NIH | National Institute of Neurological Disorders and Stroke | 2022 | $28,000 | May 14, 2022 | April 30, 2023 | LAMIA, KATJA A | reporter.nih.gov |
| 2024 SoCal Genome Stability Symposium | NIH | National Cancer Institute | 2025 | $5,000 | December 13, 2024 | December 12, 2025 | WU, XIAOHUA | reporter.nih.gov |
| Novel mechanisms regulating immunity to respiratory virus infection | NIH | National Institute of Allergy and Infectious Diseases | 2023 | $1 | August 2, 2023 | August 11, 2023 | PAUST, SILKE | reporter.nih.gov |
Funding by fiscal year
| Fiscal year | NIH awards | NIH amount | NSF awards | NSF amount |
|---|---|---|---|---|
| 2026 | 0 | $0 | 4 | $6,956,830 |
| 2025 | 182 | $164,407,597 | 3 | $2,263,500 |
| 2024 | 183 | $163,225,755 | 3 | $1,869,828 |
| 2023 | 192 | $218,629,084 | 2 | $1,155,152 |
| 2022 | 202 | $288,802,275 | 3 | $980,986 |
| 2021 | 219 | $209,174,641 | 0 | $0 |
Open federal funding opportunities
From Grants.gov: notices that funded awards in this table, and open notices on the same agency and assistance listing.
| Open opportunity | Number | Agency | Listing | Closes | Award ceiling | Why it matches |
|---|---|---|---|---|---|---|
| Change of Recipient Organization (Type 7 Parent Clinical Trial Optional) | PA-24-254 | NIH | July 12, 2027 | Not listed | Notice number printed on 3 awards here | |
| Infectious Diseases Clinical Trials Network (IDCTN) (UM1 Clinical Trial Required) | RFA-AI-27-002 | NIH | 93.855 | November 10, 2026 | Not listed | Same assistance listing 93.855 as 95 awards here |
| Clinical Research Network on Antimicrobial Resistance (UM1 Clinical Trial Required) | RFA-AI-27-005 | NIH | 93.855 | November 10, 2026 | Not listed | Same assistance listing 93.855 as 95 awards here |
| Ethical, Legal and Social Implications (ELSI) Small Research Grant (R03 Clinical Trial Optional) | PAR-25-370 | NIH | 93.855 | November 16, 2026 | $50,000 | Same assistance listing 93.855 as 95 awards here |
| Ethical, Legal and Social Implications (ELSI) Exploratory/Developmental Research Grant (R21 Clinical Trial Optional) | PAR-25-369 | NIH | 93.855 | November 18, 2026 | Not listed | Same assistance listing 93.855 as 95 awards here |
| Ethical, Legal and Social Implications (ELSI) Research (R01 Clinical Trial Optional) | PAR-25-371 | NIH | 93.855 | November 18, 2026 | Not listed | Same assistance listing 93.855 as 95 awards here |
| Intervention Research to Improve Native American Health (R01 Clinical Trial Optional) | PAR-25-379 | NIH | 93.855 | January 7, 2027 | Not listed | Same assistance listing 93.855 as 95 awards here |
| HIV/AIDS Clinical Trials Network Leadership and Operations Centers | RFA-AI-28-001 | NIH | 93.855 | January 22, 2027 | Not listed | Same assistance listing 93.855 as 95 awards here |
| HIV/AIDS Clinical Trials Network Laboratory Centers | RFA-AI-28-002 | NIH | 93.855 | January 22, 2027 | Not listed | Same assistance listing 93.855 as 95 awards here |
| HIV/AIDS Clinical Trials Network Statistical and Data Management Centers | RFA-AI-28-003 | NIH | 93.855 | January 22, 2027 | Not listed | Same assistance listing 93.855 as 95 awards here |
| HIV/AIDS Clinical Trials Network Clinical Trials Units | RFA-AI-28-004 | NIH | 93.855 | January 22, 2027 | Not listed | Same assistance listing 93.855 as 95 awards here |
| Precision and Systems Biology to Uncover the Link Between Chronic and Infectious Diseases | RFA-AI-28-014 | NIH | 93.855 | January 22, 2027 | Not listed | Same assistance listing 93.855 as 95 awards here |
| Immune Tolerance Network (UM1 Clinical Trial Required) | RFA-AI-28-005 | NIH | 93.855 | January 29, 2027 | Not listed | Same assistance listing 93.855 as 95 awards here |
| Translational Centers Using Microphysiological Systems for Infectious Diseases (U54 Clinical Trial Not Allowed) | RFA-AI-28-012 | NIH | 93.855 | January 29, 2027 | Not listed | Same assistance listing 93.855 as 95 awards here |
| Accelerating Research and Development of Next Generation Vaccines against Malaria - a Model for Mosquito-Borne Diseases (R61/R33 Clinical Trial Not Allowed) | RFA-AI-28-024 | NIH | 93.855 | February 11, 2027 | Not listed | Same assistance listing 93.855 as 95 awards here |
| NLM Institutional Grants for Research Training in Biomedical Informatics, Data Science, and AI (T15 Independent Clinical Trial Not Allowed) | RFA-LM-28-001 | NIH | 93.855 | February 11, 2027 | $775,000 | Same assistance listing 93.855 as 95 awards here |
| NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Optional) | PA-27-100 | NIH | 93.855 | April 5, 2027 | Not listed | Same assistance listing 93.855 as 95 awards here |
| NIH Small Business Technology Transfer Grant (Parent STTR [R41/R42] Clinical Trial Optional) | PA-27-102 | NIH | 93.855 | April 5, 2027 | Not listed | Same assistance listing 93.855 as 95 awards here |
| Mentored Research Scientist Development Award (Parent K01 - Independent Clinical Trial Not Allowed) | PA-24-176 | NIH | 93.855 | May 7, 2027 | Not listed | Same assistance listing 93.855 as 95 awards here |
| Mentored Patient-Oriented Research Career Development Award (Parent K23 Independent Clinical Trial Not Allowed) | PA-24-185 | NIH | 93.855 | May 7, 2027 | Not listed | Same assistance listing 93.855 as 95 awards here |
Topics of its NIH awards
- Genetics
- Biotechnology
- Neurosciences
- Infectious Diseases
- Brain Disorders
- Prevention
- Aging
- Neurodegenerative
- Rare Diseases
- Bioengineering
- Translational Research
- Immunization
Updated November 3, 2026. Read from NIH RePORTER ExPORTER and NSF Award Search. Published by NIH and NSF as U.S. government data. NIH awards are fiscal years 2021 to 2025 (NIH files published to 2026-07-09); NSF awards are fiscal years 2022 to 2026 (NSF files published to 2026-11-02). NIH amounts are the total cost of each fiscal year in the window; NSF amounts are the funds obligated in the window. Organizations are matched on the UEI. Open opportunities come from Grants.gov and match on agency and assistance listing number, and on the notice number NIH prints on an award. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.